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ABSTRACT 
 
In vivo Infection Biology of Contagious Bovine Pleuropneumonia. 
(December 2007) 
Tamara Brownsey Gull, B.A., University of Chicago; D.V.M., Tufts University School of 
Veterinary Medicine 
Chair of Advisory Committee: Dr. L. Garry Adams 
 
Contagious Bovine Pleuropneumonia (CBPP), caused by Mycoplasma mycoides 
mycoides small colony (MmmSC), is a devastating respiratory disease of cattle in Africa, 
Asia and the Middle East.  Little investigation has been done on molecular disease 
pathogenesis and host response beyond soluble cytokine detection.  This study developed 
and characterized models for three strains of MmmSC of varying severity.  Strains used 
were Gladysdale, Ondangwa and Shawawa.  Samples of bronchoalveolar lavage fluid, 
bronchial biopsy, nasal epithelial cells and blood were obtained prior to and at weekly 
time points post-infection.  Microarray analysis of RNA extracted from samples revealed 
host cellular pathways and genes important in the pathogenesis of CBPP, including 
multiple immune system and inflammatory response pathways.  A number of pathways 
whose influence on disease pathogenesis was not immediately clear were also activated, 
including pathways involved in amino acid synthesis, fat metabolism, and endocrine 
hormone responses.  Microarray results were confirmed with real-time polymerase chain 
reaction (RT-PCR) of selected genes.  Comparative RT-PCR analysis of selected genes 
  
iv 
between the three strains of MmmSC revealed genes possibly responsible for differential 
strain virulence, including interleukins 1B, 6, 8, and 18 and the gene nuclear factor of 
kappa light polypeptide gene enhancer in B cells inhibitor, alpha (NFKBIA).  A similar 
analysis of selected genes between survivors and nonsurvivors of the virulent Gladysdale 
strain of MmmSC suggested genes involved in survival, including interleukin 8, 
calmodulin 2 (CALM2), and NFKBIA.  Avenues of additional study were identified. 
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CHAPTER I 
 
INTRODUCTION 
 
BACKGROUND 
 Contagious Bovine Pleuropneumonia (CBPP) is a pulmonary disease of cattle and 
related large ruminants caused by the bacterium Mycoplasma mycoides mycoides small 
colony (MmmSC).  CBPP is the only bacterial disease on the List A of pathogens of 
concern to the World Organization of Animal Health, the Office International des 
Epizooties (OIE) (http://www.oie.int/eng/maladies/en_classification.htm#ListeA).  It is 
also a United States Department of Agriculture (USDA) high consequence livestock 
pathogen.  CBPP has profound economic effects on the cattle industry in many parts of 
Africa and coastal Europe due to overt losses and sanctions against exportation of cattle1, 
and it is estimated that losses in Africa alone exceed $2 billion per year2.  Public health 
concerns are also associated with CBPP; the incidence of childhood malnutrition 
increases in areas experiencing large-scale cattle slaughter due to CBPP3.  The disease is 
undergoing resurgence in parts of Africa1, and recent outbreaks have also occurred in 
several locations in southern Europe.  Due to its long absence from the Western 
hemisphere and the intensive high-stocking-density methods of dairy and feedlot cattle 
production, reintroduction of CBPP to the United States (whether accidental or 
___________ 
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deliberate) could have devastating effects on the cattle industry. 
 
THE DISEASE 
 Contagious Bovine Pleuropneumonia has been clinically described in cattle 
populations in manuscripts dating as far back as 15504.  It was first believed to be a 
“paralysis of the lung” and was not recognized as a contagious disease until 17945.  In the 
mid-1800s Louis Willems demonstrated that the disease could be induced via inoculation 
of naïve animals with pulmonary exudates from infected animals.  Control efforts in the 
United States were implemented prior to the identification of the causative organism and 
the disease was eradicated from the US by 1892.  The eradication of CBPP was the 
driving force behind the establishment of the Bureau of Animal Industry, the precursor to 
today’s United States Department of Agriculture.  The microbe responsible for CBPP 
was identified by Nocard and Roux in 18986, and shortly thereafter Dujardin-Beaumetz 
recognized the small size of the organism and showed how it could be separated from 
larger bacteria through filtration7.  
Cattle are the primary susceptible species for CBPP, but reports exist of affected 
water buffalo, yak, bison and reindeer4.  Small ruminants such as goats and sheep have 
been shown to harbor the mycoplasma but have not been shown to develop disease, and 
their role in the spread of CBPP is unclear8.  There may be differential susceptibilities of 
different breeds or species of cattle, but this remains unconfirmed9.  The causative 
organism is transmitted by direct contact. 
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Clinical signs in affected animals include tachypnea, fever, cough, respiratory 
distress, lethargy, inappetence, weight loss and pleurodynia.  Decreases in or cessation of 
milk production may occur in dairy animals.  Lameness and increased recumbency are 
seen in younger animals with joint involvement.  Direct economic losses occur from 
death, weight loss, decreased milk yield, decreased working ability and decreased 
fertility.  Indirect effects include an increase in human malnutrition in affected countries, 
particularly those imposing slaughter control measures3.  Although the disease is 
characterized by respiratory signs, animals develop mycoplasmemia and demonstrate 
systemic effects.  At necropsy, animals with CBPP demonstrate often-unilateral 
serofibrinous pleuropneumonia characterized by severe interstitial edema and fibrosis4,10.  
Large quantities of pleural fluid may be found in acute cases, and fibrinous adhesions 
between pulmonary visceral and parietal pleura are common.  Pleura are thickened with 
layered fibrin deposits frequently described as omelette-like.  The lungs are often 
reported to have a marbled appearance due to thickening of interlobular septae and color 
changes.  Necrotic areas of lung may develop, and these areas may become sequestered 
via formation of a thick layer of fibrous tissue.  These sequestra may persist for months 
or years after an affected animal has apparently recovered from the disease.  Thoracic 
lymph nodes in animals with CBPP may be enlarged and edematous and may 
demonstrate necrotic areas; mycoplasma can be isolated from the lymph nodes11.  Septic 
arthritis, with joint distention, synovitis and cartilaginous erosions, may be seen in 
younger animals (usually <6 months of age). Renal infarcts have been reported in all age 
groups12.  Exudative pericarditis and peritonitis have also been reported.  The causative 
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organism has been isolated from lymph, serum, plasma, urine and semen, further 
demonstrating the systemic nature of the disease11-16. 
The incubation period of naturally-occurring disease varies between 5-207 days, 
but is normally between 31-45 days17. There are distinct differences in morbidity and 
mortality between the African and European strain clusters of MmmSC; some African 
strains may demonstrate up to 90% morbidity and up to 70% mortality, while European 
strains often show only up to 30% morbidity and <10% mortality.  Disease may be 
hyperacute, with severe pleuropneumonia and death in 1-10 days; acute with cough, 
fever, pneumonia and pleurodynia lasting ten days to several weeks; subacute with 
intermittent fever, anorexia and mild pneumonia; and chronic. Cattle may shed the 
organism for weeks prior to demonstrating illness, and prior to seroconversion.  The 
chronic form of CBPP may occur upon initial infection or following either acute or 
subacute disease and results in the development of encapsulated infected sequestra within 
pulmonary tissue. Abattoir studies have shown that up to 80% of animals “recovered” 
from CBPP had sequestra at slaughter17. Sequestra are believed to be one of the methods 
by which CBPP is maintained in cattle populations, as animals with sequestrae may 
periodically shed MmmSC18. Intermittent shedding may continue for up to two years. So 
while subacutely or acutely-infected animals may only appear clinically affected for 
weeks, the actual duration of infection with MmmSC may be considerably longer4.  The 
dynamics of CBPP infection have been mathematically modeled in both sedentary19 and 
nomadic20,21 cattle populations in Africa using incidence data, and both models support 
the presence of carrier animals in maintaining the disease within their respective 
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populations. The factors governing recrudescence of mycoplasma shedding are 
undetermined; an experimental attempt to reactivate a sequestered infection was 
unsuccessful22.  
 
INCIDENCE AND PREVALENCE 
CBPP has primarily been a problem in Africa, particularly the sub-Saharan and 
central regions.  It had been on the decline in the late 1960s and 1970s due to widespread 
vaccination programs in many affected countries.  However, the decrease in government-
sponsored vaccination programs since the 1980s has allowed the disease to spread 
virtually unchecked in many areas.  Several countries previously thought free of the 
disease have experienced recurrences in the last two decades1, and reports indicate that 
these new outbreaks are of significantly higher morbidity23.  If anything, CBPP incidence 
is underreported in Africa due to inadequate surveillance.  The disease remains of vital 
importance to the African cattle industry and, with the increasing control of rinderpest, 
has become the major infectious disease of livestock on the African continent (Figure 1). 
 While Europe has yet to experience any CBPP outbreaks in the 21st century, 
several outbreaks occurred in the 1990s in Portugal, Spain and Italy.  Europe has 
experienced outbreaks at least once per decade despite vigorous eradication efforts24.  
The Middle East has had outbreaks in Saudi Arabia, Pakistan, Kuwait and Qatar in the 
past decade, and Southeast Asia has had outbreaks in Bangladesh and Myanmar.  
Sporadic outbreaks have been seen in China and possibly Mongolia as well.  However, 
many Asian countries have not reported CBPP status to the OIE, so actual incidence 
  
6 
 
Figure 1. Reported Occurrence of Contagious Bovine Pleuropneumonia in Africa. 
January through June 2005219. 
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may again be underreported. 
CBPP was eradicated from the United States in 1892 and from Australia in 1973.  
Eradication in both the U.S. and Australia was dependent on strict control of cattle 
movement, herd-scale slaughter and financial remuneration to owners. Unfortunately 
such methods are not feasible in undeveloped nations, as they lack the governmental and 
civil resources to effectively restrict movement and the financial resources to compensate 
animal owners.  Additionally, cultural issues involving traditional nomadic lifestyles and 
migration patterns and the social status value of cattle often make animal owners 
unwilling to comply with such movement control and eradication measures.  As no viable 
treatment for CBPP exists, vaccination is the control method of choice at this time.  
However, there are difficulties with this method that will be discussed. 
 
PREVENTION AND TREATMENT 
Vaccination strategies have been employed against CBPP since at least the latter 
half of the 19th century.  Early vaccination measures involved inoculating pleural fluid 
from infected animals into naïve animals.  This method of vaccination resulted in the 
death of 1-10% of vaccinates25.  Since then, vaccination against CBPP has remained a 
struggle26. Multiple vaccine formulations have been developed but all have shown 
drawbacks including the induction of undesirable side effects and lack of consistent 
protective or long-lived immunity25.  Over ten inactivated vaccines have all failed to 
provide adequate protection, while occasionally resulting in sensitization of inoculated 
animals to the organism.  Attenuated (by serial subculture) vaccines have frequently 
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resulted in variable protection, severe local reactions, clinical disease and occasionally 
death of vaccinated animals26-28. The currently in-use T1/44 attenuated vaccine requires 
annual revaccination for protection, which is economically and logistically impractical in 
many African countries1.  It has been reported to cause clinical disease29, and requires 
careful handling to maintain efficacy.  It is, advantageously, specifically identifiable via 
PCR30.  Investigation is ongoing toward specific-component vaccines for CBPP31, but 
efforts are hampered by the expense and logistical difficulty of conducting field trials. 
Genetically-modified vaccine strains of MmmSC have not been attempted.  Development 
of new CBPP vaccines is unlikely given the political, economic and logistic challenges 
present in endemic areas2,32. 
No effective antibiotic therapy is available for CBPP.  While antibiotic therapy 
has been shown to resolve the clinical signs of CBPP, lesions were still present at 
necropsy in treated animals33,34.  Fluoroquinolone antibiotic treatment has been shown to 
reduce the spread of the disease to in-contact susceptible animals, but the treated animals 
maintained the characteristic necropsy lesions35. It has been suggested that treatment of 
CBPP-infected animals with antibiotics or anti-inflammatory drugs may contribute to the 
development of the chronic carrier state and sequestra formation, possibly since the 
majority of antibiotics used based on in vitro sensitivities are bacteriostatic36.  No studies 
have specifically investigated this hypothesis.  Treatment of CBPP-infected animals with 
antibiotics is actively discouraged by the OIE.   
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THE ORGANISM 
 MmmSC is in the class Mollicutes, order Mycoplasmatales and family 
Mycoplasmataceae.  Like all mycoplasmas, it is a wall-less prokaryote with a low G+C 
content (24%) and is among the simplest self-replicating organisms known37. MmmSC is 
a member of the M. mycoides cluster, a closely-related group of mycoplasmas that cause 
disease in ruminant species (Table 1).  The classical M. mycoides cluster contains six 
organisms that share many biochemical and genetic determinants, and differentiation 
between the organisms can be difficult10,38. Interestingly, the bacteria in the M. mycoides 
cluster appear to be more closely related to organisms in genii Entomoplasma, 
Mesoplasma and Spiroplasma than to other organisms in genus Mycoplasma39,40. 
MmmSC, like most mycoplasmas, is highly host-specific in its ability to cause disease.  
There are more than 60 known strains of MmmSC divided into two clusters, 
African/Australian and European.  The full genome sequence (1.2 Mbp) has been 
published only for the MmmSC type strain PG141, but the genome for the African strain 
Shawawa has also been sequenced [S.J. Geary, personal communication]. Initial 
comparison of the two genomes has revealed minimal differences.  Although the type 
strain is known to be pathogenic, it fails to fall into either of the two major geographic 
clusters and its origin is unknown42.     
The African/Australian and European clusters of MmmSC are primarily 
differentiated by an 8.84kb deletion in the genome of European strains and an associated 
decrease in virulence, with the African strains demonstrating significantly higher  
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Table 1. Diseases caused by mycoplasmas of the classical M. mycoides cluster. Table 
adapted from Persson, 2002.  
 
Species Reference 
Strain 
Main host 
species 
(secondary 
species) 
Disease(s) 
M. capricolum 
capricolum 
California 
kid T 
Goats, sheep 
(cattle) 
Arthritis, mastitis, 
pneumonia 
M. capricolum 
capripneumoniae 
F38 T Goats (sheep) Pleuropneumonia 
(CCPP) 
M. mycoides capri PG3 T Goats Arthritis, 
pleuropneumonia 
M. mycoides 
mycoides LC 
Y-goat R Goats, sheep 
(cattle) 
Arthritis, peritonitis, 
septicemia, 
pleuropneumonia 
M. mycoides 
mycoides SC 
PG1 T Cattle (buffalo, 
goats, sheep) 
Pleuropneumonia 
(CBPP), arthritis 
Mycoplasma bovine 
group 7 
PG50 R Cattle (goats, 
sheep) 
Arthritis, mastitis, calf 
pneumonia 
T
 Type strain 
R
 Reference strain 
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virulence43.  There has been intense interest in investigating virulence determinants of  
MmmSC and other mycoplasmas, since they are not known to secrete toxins or to express 
specific adherence factors, yet demonstrate dramatic variations in disease severity.  Their 
minimal genome also suggests that so-called virulence factors likely are also integral to 
the normal metabolism of the mycoplasma.  Sequencing of the deletion area present in 
the African strains has been conducted and has tentatively identified five open reading 
frames (ORFs) including a membrane lipoprotein and a putative abc transporter protein43.  
No research has been published investigating the virulence of single deletion mutants of 
these five ORFs.  Two of these five ORFs have been identified as gtsB and gtsC, which 
are involved in glycerol transport.  Hydrogen peroxide is an end-product of glycerol 
metabolism, and strains naturally lacking these genes produce less hydrogen peroxide in 
vitro44. This difference in hydrogen peroxide production has been hypothesized to be a 
virulence factor differentiating the African and European strains of MmmSC45. The 
membrane lipoprotein encoded in the deletion area, LppB, is present in several other 
bacteria in the M. mycoides cluster43,46.  It has also been proposed as a virulence factor 
simply because of its probable surface membrane location, where it might interact with 
host cells. 
MmmSC is known to undergo high-frequency surface antigen variation, which 
complicates reliable serologic detection of the organism47,48.  This phase variation of 
surface lipoproteins has been proposed as a virulence factor47, and several other 
lipoproteins whose impact on virulence is unknown have been identified as antigenic 
epitopes43,49-52.  Investigation has revealed at least eight immunogenic MmmSC epitopes 
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against which an infected host develops a serum antibody response, and six of these are 
known to be lipoproteins53, which supports the possible role of lipoproteins as virulence 
factors.  Additionally, the galactan capsule of MmmSC may be a virulence determinant.  
Galactan is known to promote microbial binding to host cell surfaces and to provide 
resistance to phagocytosis.  Its similarity to bovine pneumogalactan, produced by 
respiratory epithelial cells, may induce the formation of autoantibodies.  Finally, injection 
of capsular galactan is also known to induce toxic effects on the host54,55. 
Another potential virulence determinant suggested in recent research is a single 
nucleotide polymorphism (SNP) within the gene for 6-phospho-β-glucosidase (bgl).  
Strains of MmmSC with the isoform Bgl Val204 demonstrate higher pathogenicity than 
those with Bgl isoform Ala20456.  The proposed mechanism is that strains with the Val204 
isoform have decreased hydrolyzing activity and may be better equipped to survive in 
environments containing high levels of β-D-glucosides such as the bovine lung.  
Investigation of virulence factors of mycoplasmas is complicated by the difficulty of 
genetically modifying these organisms.  Mycoplasmas are remarkably resistant to 
classical methods of mutagenesis, a characteristic that has frustrated researchers for 
decades.  As examples, transformation has only been possible in mycoides cluster 
organisms in the presence of high concentrations of polyethylene glycol, and then at very 
low success rates compared to many other bacterial species57.  Additionally, only two 
transposons, Tn916 and Tn4001, have been successfully applied in mycoplasmas58,59, 
although these have not been applied to MmmSC.  However, the generation of artificial 
oriC plasmids which have successfully been used to transform MmmSC and the related 
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organism Mycoplasma mycoides mycoides large colony (MmmLC)60 may herald 
incipient advances in the manipulation of the mycoides cluster genome.  Unfortunately, it 
appears that plasmids used for transformation may need to be individually designed for 
the target mycoplasma species, as these artificial plasmids exhibit often stringent host 
specificity60. 
Mycoplasmas are often characterized by the presence of insertion sequences 
coding for putative transposases in their genomes.  MmmSC is known to contain three 
such insertion sequences: ISMymy161; IS163462; and IS129663.  Approximately eight 
copies of ISMymy1 occur in all tested strains of MmmSC61, and this sequence is also 
found in some strains of Mycoplasma bovis.  Roughly 60 copies of IS1634 occur in all 
strains of MmmSC62, but no other mycoplasmas.  Variable numbers of copies of IS1296 
occur, and this IS may be used to differentiate European versus African cluster strains of 
MmmSC63.  The presence of these putative transposases in the mycoplasma genome is 
difficult to explain given the resistance of the mycoplasmas to deliberate transposon 
insertion and the apparent stability of a genome that includes what appear to be multiple 
ancestral transposons. 
 
HOST RESPONSE TO INFECTION 
The mechanisms by which MmmSC evades or circumvents the host immune 
response are poorly understood, as are the details of how the host responds to infection. 
In vitro studies have demonstrated that pathogenic strains of MmmSC induce TNFα 
production by alveolar macrophages but fail to induce procoagulant activity or nitric 
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oxide formation64.  An ex vivo experiment generated evidence that IFNγ-producing CD4+ 
T cells were necessary for recovery from CBPP, but this study did not differentiate 
between recovered animals with necropsy lesions (chronically-infected animals) and 
those without (animals in which evidence of disease was no longer present)65.  A follow-
on study suggested that live MmmSC could secrete a substance that induced apoptosis in 
both lymphocytes and granulocytes66. Although this substance has not been further 
defined, the study authors suggest that hydrogen peroxide should be considered for the 
role. In vivo studies of the immune response have demonstrated that cell-mediated 
immunity is important in the resolution of clinical signs65.  Additionally, MmmSC 
appears to be able to inhibit concanavalin A-induced blastogenesis and IFNγ production 
by PBMC and lymphocytes67, further intimating that cell-mediated immunity may be 
necessary for control of infection.  Contrary to these observations is one study that 
showed that passive immunity to CBPP could be transferred via serum68.  Investigation of 
the humoral immune response to infection has shown a potent IgA response local to 
infection and a weaker systemic IgG response53, and the response is stronger in animals 
infected with more virulent strains of MmmSC. A different study suggested that 
increased IgA production was correlated with less severe disease, while other 
immunoglobulin isotypes were similar between animals with acute disease and those with 
subacute or chronic disease69. Multiple studies have suggested that the magnitude of the 
host response is in part responsible for the severity of lesions observed in CBPP, but the 
extent of this contribution is undetermined31,70,71. 
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ANIMAL MODELS OF DISEASE, DETECTION AND VACCINE STUDIES 
 Most in vivo studies of CBPP have used cattle, as it has proven extremely difficult 
to cause disease in other ruminant species and transmission in other ruminant species 
does not appear to occur as readily as in cattle.  A few mouse models have been used, 
particularly in vaccine studies, but mice fail to develop the characteristic lesions of CBPP 
and researchers instead rely on the induction of mycoplasmemia to evaluate response27,72-
77
.  Multiple bovine models have been used for infection, including direct contact, blind 
endotracheal or endobronchial inoculation and nasal inoculation9,22,53,65,69.  Previous 
models inoculated various growth media (agar, Hayflick medium, etc.) in addition to the 
bacterial isolate, and bacterial numbers were variable22,65,78.  Inocula could not be 
quantified in models of direct contact infection.  Species, breed or type of cattle were 
frequently not reported, and some studies of natural infection did not report strain type of 
the organism beyond ‘naturally-occurring field strain’. Dose dependence has been cited 
as a factor in both disease induction and vaccine efficacy26,27,34,74,79.   
 In vitro studies have used fetal bovine nasal epithelial cell cultures, bronchial 
epithelial cultures, or bovine macrophages or lymphocytes45,64,66.  None of these systems 
replicates the complex environment found in the lung.  Cultured cell lines, while 
providing the target cell type, fall short of replicating the animal environment.  Epithelial 
cells are polarized in vivo, and each cell surface has very different roles, surface 
molecules, and capabilities.  Polarized epithelial cell models are difficult to construct and 
maintain, and none of the MmmSC studies have made use of them.  Single cell type 
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models also eliminate the complex interactions seen between cells in the animal host, 
such as the cellular trafficking between epithelial cells and the subepithelial cell layers, 
endothelial cells, white blood cells and the cells of the immune system.  Even the 
proportions of type 1 and type 2 respiratory epithelial cells in a culture system may affect 
the results of an in vitro experiment by altering the amount of secreted substances such as 
mucus and surfactant.  While easier to manipulate than the whole animal model, the 
drawbacks of in vitro models may present difficulties in interpreting results.   
No studies have investigated the host global immune response to infection with 
MmmSC; all have focused on one arm of the immune system.  The lack of confluence of 
models makes comparisons of their conclusions difficult.  There is also a lack of studies 
investigating differences during the course of infection in recovered animals with and 
without lesions at necropsy.  Observers of CBPP outbreaks since 187325 have 
acknowledged the existence of a ‘resistant’ subgroup of animals that never develop 
lesions or disease, but little has been done to investigate this phenomenon.  One 
preliminary study investigating genetic markers of susceptibility identified the BoLA 
allele cbb (DRB3*2101) as being predominantly associated with resistance to CBPP and 
the lba allele being associated with susceptibility, although study size precluded 
significance25. 
Diagnosis of infection is complicated.  Sample source has a large impact: blood is 
easy to obtain but less reliable, while bronchial secretions are more reliable but more 
labor-intensive to acquire.  Nasal secretions are unreliable sample sources, and urine has 
only been minimally investigated16,80-82.  The current “gold standard” herd-level blood 
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test per the OIE is the complement fixation test (CFT).  This test is extremely specific 
during acute infection, but is less useful in animals during both early and chronic 
infection83. In addition, the CFT is complex and requires stringent controls and technical 
training; it has proven difficult to adapt to a pen-side format.  Some chronically-infected 
animals fail to seroconvert on the CFT despite intermittently shedding the organism (T. 
Gorton, unpublished observations).  Even animals with acute disease typically do not 
seroconvert until after the onset of clinical signs.  Passive hemagglutination tests may 
help identify early infections through detection of the IgM response, but they lack 
sensitivity and specificity18,84.  A latex agglutination test has been developed that 
demonstrates sensitivity similar to CFT but is much simpler to perform; however, it 
suffers the same drawbacks as CFT in early or chronic infection85,86.  Culture of the 
organism is time-consuming due to slow growth and the requirement for selective media; 
even after culture, specific biochemical tests are required to definitively identify the 
organism.  Postmortem use of immunohistochemistry has proven useful where culture 
techniques are inappropriate11, but still suffers cross-reactivity with other mycoides 
cluster organisms.  Other serologic tests have been plagued by cross-reactivity of 
antibodies within the M. mycoides cluster of organisms, resulting in low sensitivity and 
specificity of any single serologic test87.  Other methods of detection have been proposed 
for MmmSC. Both ELISA and immunoblot assays suffer from serologic cross-reactivity, 
and are not amenable to field use88,89.  A number of PCR-based tests have been developed 
that are sensitive and specific, but require restriction endonuclease digestion and gel 
electrophoresis after PCR for results to be useful38,80,90-94.  None of these PCR-based tests 
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have proven adaptable to field conditions.  A real-time PCR test was recently shown to be 
sensitive and specific, and required no special processing of a sample of bronchial 
secretions95.  This test was developed for use in a portable platform, but no field trials 
have been conducted.  A sensitive, specific and field-adaptable test for MmmSC, using an 
easily-obtainable bovine sample, has so far remained elusive.   
 
AIMS 
 The overall aim of this study is to investigate the temporal global host response to 
infection with MmmSC at the transcriptional level, in both acute and chronic models of 
infection.  The second chapter of this dissertation discusses the development of the 
models, timelines, clinical findings and morphological findings.  Both acute and chronic 
models will be described from infection through chronicity.  The third chapter will 
investigate the temporal transcriptional response of the bovine host in several tissue 
types.  This discussion will focus on the identification, through dynamic Bayesian 
modeling analysis, of specific mechanistic genes and pathways that appear relevant 
during the course of infection.  The fourth chapter will describe selected genes in the 
contexts of differential strain severity and survival versus nonsurvival.  Cell types 
investigated will include macrophages and neutrophils obtained via bronchoalveolar 
lavage, bronchial epithelial cells obtained via bronchial biopsies, nasal epithelial cells and 
blood.  Selected genes and cellular pathways will be discussed in greater depth in the 
context of published knowledge on MmmSC and Contagious Bovine Pleuropneumonia. 
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CHAPTER II 
 
ACUTE AND CHRONIC MODELS OF CONTAGIOUS BOVINE 
PLEUROPNEUMONIA 
 
INTRODUCTION 
Previous studies involving bovine models of CBPP have used a variety of 
isolates, inoculation methods and bacterial numbers.  Due to the difficulty of establishing 
a viable in vitro model of CBPP, in vivo studies are necessary in order to further 
determine the effects of infection on the bovine host.  While direct contact with cattle 
already shedding the organism is the natural method by which naïve animals are 
infected37, this manner of infection can be unreliable, does not permit quantitation of the 
infective dose, and results in prolonged incubation periods before animals demonstrate 
disease.  With a direct-contact model of infection it is impossible to determine when, or 
even if, a particular susceptible animal received an infective dose of organism.  Dose 
dependence has been cited as a factor in both disease induction and vaccine 
efficacy26,27,34,74,79.  Inoculation of cattle by other routes (nasal or endobronchial) allows 
accurate determination of both quantity of organism and incubation period.  Infection of 
cattle with field strains of MmmSC exhibiting differing virulence under the same 
experimental protocol should permit better comparison of the effects of these strains on 
the bovine host. Side-by-side evaluation of these acute and chronic models of CBPP 
infection using identical techniques may allow more relevant comparisons to be made 
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between the models and could lead to the discovery of subtle differences in both disease 
pathogenesis and host immune response. 
The goal of this study was to infect separate groups of cattle with identical 
numbers of three different strains of MmmSC and observe their clinical responses, death 
versus recovery, and pathologic lesions at necropsy.  This study produced both acute and 
chronic disease models which may be directly compared.  In addition, sampling of 
bronchoalveolar lavage fluid, nasal epithelial cells, blood and bronchial epithelial cells 
was done at multiple time points following infection; samples obtained were used in 
other studies of CBPP.  Side-by-side evaluation of acute and chronic models of CBPP 
infection using identical techniques should allow more relevant comparisons to be made 
between the models and may suggest avenues of exploration in both disease pathogenesis 
and host immune response. 
 
MATERIALS AND METHODS 
Experimental animals.  All experimental protocols were approved by the 
USDA/DHS Plum Island Foreign Animal Disease Center (PIADC) Animal Care and Use 
Committee. Mixed-breed Bos taurus cattle between 6-8 months of age were obtained 
from a commercial source commonly used by the USDA Agricultural Research Service.  
Each animal was individually identified by a numbered ear tag. Animals received an 
initial physical evaluation and anthelmintic treatment with ivermectin (Ivomec injectable 
1% solution, 200 µg/kg SQ, Merial, Duluth GA) before being used for the study. Animals 
were acclimated to the experimental rooms for three weeks prior to the start of the 
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experiment.  They were housed in groups of five in separate rooms of the indoor 
biocontainment facility at the USDA/DHS Plum Island Foreign Animal Disease Center.  
Alfalfa pellets and fresh water were provided ad libitum. Pens were cleaned daily. All 
animals were observed by experienced husbandry staff at least once daily, and rectal 
temperatures were taken weekly prior to inoculation and daily thereafter.  Temperatures, 
clinical signs of illness and attitude were recorded on daily observation sheets.  
Sample collection. At the start of each sampling procedure, individual animals 
were restrained in a squeeze chute and headgate integral to the room. A rope halter was 
applied and used for further restraint as needed. Two 10ml blood samples were obtained 
via jugular venipuncture.  One blood sample was aliquoted into Tri-Reagent BD 
(Molecular Research Center, Cincinnati OH) at a 1:5 ratio for RNA isolation. The other 
was allowed to clot and be centrifuged for serum.  Nasal swabs for culture and PCR were 
obtained using a sterile guarded rayon uterine culture swab (Jorgensen, Loveland CO).  
The guarded swab was inserted up the left nostril 10-15cm, the swab extended and the 
mucosa gently rubbed.  The swab was retracted into its guard before withdrawal.  A 
sample of nasal mucosal cells was obtained with a sterile guarded uterine cytology brush 
(Jorgensen).  The guarded brush was inserted up the left nostril to the level of the medial 
canthus of the eye, the sampling brush was extended and the mucosa swabbed 5-10 times.  
The brush was retracted into its guard prior to withdrawal.  The brush assembly was 
amputated into a 2ml microcentrifuge tube containing RNAlater (Ambion, Austin TX) 
and stored at 4oC until further processing. Prior to inoculation with MmmSC, all cattle 
underwent endoscopic bronchalveolar lavage (BAL) using a 1.6m videocolonoscope 
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(Olympus, Center Valley PA).  The endoscope was introduced through the right nostril 
and visually guided through the larynx and into the right caudal lung lobe until bronchial 
size prevented further advancement.  Two aliquots of 60ml sterile physiologic saline 
(Abbott, Abbott Park IL) were instilled through a sterile single-use double-guarded 
aspiration catheter (Mila International, Erlanger KY) threaded through the biopsy channel 
of the endoscope.  Each aliquot was instilled and reaspirated into the delivery syringe.  
One 2ml aliquot of recovered fluid was placed on ice for culture and PCR of MmmSC.  
The remainder of the aspirated BAL fluid was aliquoted into 2ml microcentrifuge tubes 
and centrifuged at 10,000 x g at room temperature for 10 minutes to pellet the cells.  The 
supernatant was discarded and cells were resuspended in 2ml RNAlater (Ambion).  
Resuspended cells were stored at 4oC until further processing. Following the BAL, the 
endoscope was withdrawn until a bronchial bifurcation could be visualized.  Five 
milliliters of 2% lidocaine (AstraZeneca, Wilmington DE) was instilled through the 
biopsy channel.  A 2.5mm biopsy forcep (Precision Endoscopy, Hunt Valley MD) was 
passed down the biopsy channel.  Two bronchial mucosal biopsies were obtained and 
placed in RNAlater.  Biopsy specimens were stored at 4oC until further processing.  
Following the biopsy procedure, the endoscope was withdrawn completely.  The 
endoscope was disinfected and the biopsy channel flushed thrice with 70% isopropanol 
and rinsed with sterile water prior to use on the next animal.  Following the sampling of 
all cattle in a treatment room the endoscope was disinfected as described above, then 
sterilized in glutaraldehyde solution (Cidex, Johnson & Johnson, New Brunswick NJ) per 
the manufacturer’s instructions.  Sterilized endoscopes were rinsed with sterile water and 
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stored in the anteroom of the animal housing room for the next sampling day.  The 
endoscope was not transferred between animal rooms; a separate scope was used in each 
room. 
MmmSC strains. MmmSC Australian strain Gladysdale (Animal and Plant 
Health Inspection Service, USDA, Plum Island Animal Disease Center, Greenport NY) 
was used for the acute infection model and African field strains Ondangwa and Shawawa 
(Dr. Leon Prozesky, University of Pretoria, Onderstepoort, South Africa) were used for 
the chronic models. Strains were grown in Fortified Commercial medium (Difco, 
Franklin Lakes NJ) at 37oC for 72 hours and were centrifuged for 15 minutes at 12,000 x 
g and 4oC, then resuspended in phosphate buffered saline prior to inoculation.  
Pulmonary infection.  One day after the preinoculation sampling, 1010 MmmSC 
suspended in 2ml phosphate buffered saline were inoculated into the right caudal lung 
lobe via an aspiration catheter threaded through the endoscope biopsy channel.  The 
catheter was flushed with 10ml PBS and the endoscope withdrawn.  Sampling as 
described above was conducted at Day 1 post-infection and weekly until the conclusion 
of the experiment. 
Evaluation of clinical disease. Animals were observed daily by animal 
husbandry staff familiar with clinical signs of CBPP and weekly by a board-certified 
large animal internist and a board-certified pathologist.  Rectal temperatures and clinical 
observations were recorded on daily observation sheets.   
Necropsy procedure. Cattle were euthanized with a pentobarbital overdose 
administered intravenously (Sleepaway, 26mg/lb, Fort Dodge Animal Health, Fort Dodge 
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IA) and necropsied at the time that clinical signs of disease suggested that death was 
imminent. If clinical disease was inapparent or observed but resolved, animals were 
euthanized and necropsied between Days 36-43 post-infection depending on necropsy 
room and animal handler availability.  Euthanized animals were immediately necropsied 
by a board-certified pathologist assisted by a board-certified large animal internist.  A 
postmortem bronchoalveolar lavage was done using one 60ml aliquot of physiologic 
saline and an aspiration catheter after the lungs were removed from the thoracic cavity, 
and samples were handled as described above.  All organs were examined for gross 
pathology. Samples of lung, tracheobronchial lymph node and joint, as well as any other 
grossly abnormal tissues, were fixed in 10% buffered formalin for histopathology.  Tissue 
samples of lung, bronchial mucosa, tracheobronchial lymph node and kidney were 
minced and placed into a 2ml microcentrifuge tube in RNAlater, then stored at 4oC until 
further processing. Carcasses were incinerated in accordance with PIADC protocols. 
Culture of MmmSC.  Aliquots of BAL fluid and nasal swabs were plated or 
swabbed onto Fortified Commercial agar (Difco) and grown at 37oC for a minimum of 72 
hours.  Subculture was performed if necessary.  Colony morphology was evaluated under 
a dissecting microscope.  Representative colonies were selected for evaluation by PCR. 
PCR of MmmSC from BAL fluid.  One milliliter aliquots of BAL fluid were 
centrifuged at 12,000 x g for 15 minutes at 4oC.  The supernatant was removed and the 
pellet resuspended in 500 µL phosphate buffered saline.  The samples were boiled for 10 
minutes.  Next, 1 µL of the sample was combined with 0.9 µM concentration of each 
forward and reverse primer, 0.1 µM concentration of probe and TaqMan Universal PCR 
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Master Mix (Applied Biosystems) in a total volume of 20 µL.  Real-time PCR was 
performed with this reaction mixture on the SmartCycler I (Cepheid, Sunnyvale CA).  
Reaction conditions included 2 minutes at 50oC followed by 10 minutes at 95oC and then 
40 cycles of 15 seconds at 94oC and 60 seconds at 60oC.  The default threshold limit was 
set at 30 and the optics detection was turned on for the cycle steps at 60oC.  Data were 
exported to Microsoft Excel for analysis. Primers used were sequence 5’-
ATGGACGAAAGTCTGATGAAGCAATGC-3’ and 5’-
TCTGGTAAGGTACTGTCAAGATAAAGTCAT-3’, and the probe used was sequence 
5’-6FAM-ACAACAGAGATTTACAAC-MGBNFQ-3’, in which 6FAM is the 
fluorescent dye 6-carboxyfluorescein and MGBNFQ is a minor groove binding non-
fluorescent quencher.  This probe targets a unique polymorphism within the MmmSC 
16S RNA gene rrnA95. 
Histopathology. Tissues collected at necropsy and fixed in 10% buffered 
formalin were embedded in paraffin and sectioned at 5 µm onto glass slides for light 
microscopy.  Slides were stained with hematoxylin and eosin and scored by a board-
certified pathologist familiar with CBPP lesions and blinded as to with which strain the 
steer had been infected. 
Electron microscopy. Bronchial epithelial tissues collected at sampling time 
points via biopsy forceps and at necropsy were processed for thin section analysis.  Small 
pieces of bovine lung containing characteristic lesions were fixed with a solution 
containing 10% neutral buffered formalin.  After 1-5 days, necropsy tissues were 
trimmed into 3 mm x 10 mm strips and fixed with a solution containing 2.5% 
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glutaraldehyde in 0.1M cacodylate buffer (pH 7.4) for 24 hrs.  Biopsy samples were 
processed similarly, but were not trimmed.  After rinsing with 0.1M cacodylate with 10% 
sucrose, the tissue was post-fixed with 1% osmium tetroxide and 1.5% potassium 
ferricyanide for 1 hr at 4oC. The tissues were stained en bloc with 2% aqueous uranyl 
acetate, dehydrated with an acetone series and embedded in Spurr’s resin.  Ultrathin 
sections were cut with a diamond knife and contrasted with 2% methanolic uranyl acetate 
and Reynolds lead citrate.  Images were captured with a Hitachi T-7600 electron 
microscope operating at 80 kV with an AMT digital camera.   Transmission electron 
microscopy of selected samples was performed by an experienced electron microscopist. 
Serology. Serum samples collected from the cattle infected with strains 
Ondangwa and Shawawa were tested by the complement fixation test in the USDA 
APHIS laboratory at Days 0, 24 and 42 post-infection.  Cattle infected with strain 
Gladysdale were not tested during this experiment, but animals endobronchially infected 
with this strain typically seroconvert between Days 7-14 post-infection96 (APHIS, 
unpublished data). 
 
RESULTS 
 Clinical observations.  Cattle infected with strain Gladysdale were the first to 
show clinical signs.  Two animals exhibited increased temperatures (>103oF) by Day 2 
postinoculation, and all but one were febrile by Day 4 (Figure 2).  One animal did not 
become febrile until Day 6, and this animal (#34) never exhibited a fever of above 105oF.  
In animals that survived, temperatures returned to normal by Day 15 post-infection.   
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Two Gladysdale-infected animals developed increased respiratory rates by Day 3 
post-infection. One animal became inappetent on Day 5, two days after it started showing 
fever of >105oF.  A second animal became inappetent on Day 6.  By Day 7 both of these 
animals had developed cough and lethargy, and by Day 9 both were standing with 
abducted elbows and had increased respiratory effort.  One animal had observable weight 
loss by Day 7, although the isolation facilities prohibited actually weighing the cattle.  
Unilateral right-sided pleurodynia was evident by Day 9 in both animals.  One of these 
animals developed joint effusion in a tibiotarsal joint on Day 7, and was grade 4/5 lame 
on the limb (toe-touching lame).  One animal demonstrated intermittent open-mouth 
breathing on Day 9.  The two severely-affected animals (#29 and #31) became moribund 
and were euthanized on Days 10 and 13 post-infection respectively (Table 2). 
The three less-severely-affected Gladysdale-infected animals developed increased 
respiratory rates by Day 8, but never became inappetent.  Two exhibited mild unilateral 
right-sided pleurodynia.  No open-mouth breathing, increased respiratory effort, altered 
stance or lameness were observed.  Two of the three showed intermittent cough between 
Days 9-14.  One animal showed no clinical signs of illness except slightly increased 
respiratory rate and moderate fever, and these resolved by Day 10. 
In animals infected with strain Ondangwa, only one animal exhibited a mild increase in 
temperature (102.6-103.6oF) between Days 4-7.  Two animals showed mild cough and 
slightly increased respiratory rates between Days 7-12.  One animal infected with strain 
Shawawa showed fever between 102.6-103.6oF on Days 4-6 only.  This animal also 
exhibited a mild cough between Days 6-9.  No other clinical signs consistent  
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Figure 2.  Rectal temperatures of animals infected with MmmSC. A. strain 
Gladysdale; B. strain Ondangwa; C. strain Shawawa.  Two Gladysdale-infected animals 
were euthanized prior to the conclusion of the experiment due to severe disease. 
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Table 2.  Clinical results of infection with MmmSC.  Fifteen naïve cattle were 
endobronchially infected with one of three strains of MmmSC and followed through 
euthanasia and postmortem.  Animals annotated as “died” were euthanized in extremis.  
LN = enlarged tracheobronchial lymph nodes; BIP = bronchointerstitial pneumonia; PP 
= pleuropneumonia. 
Animal Strain Clinical Signs Outcome Postmortem 
7 Shawawa None survived None 
9 Shawawa None survived None 
11 Shawawa Fever, cough survived Mild chronic focal 
BIP 
12 Shawawa None survived Minimal chronic focal 
BIP 
13 Shawawa None survived Mild chronic focal 
BIP 
3 Ondangwa Cough, tachypnea survived Severe chronic focal 
BIP, LN 
4 Ondangwa None survived Minimal subacute 
focal BIP, LN 
6 Ondangwa Fever, cough, 
tachypnea 
survived Severe chronic 
focally extensive BIP, 
pleural adhesions, 
LN  
8 Ondangwa None survived LN 
10 Ondangwa None survived Moderate chronic 
focal BIP, LN 
29 Gladysdale Fever, cough, 
tachypnea, dyspnea, 
lameness, inappetence, 
pleurodynia, open-
mouth breathing 
died 
(Day 10) 
Pleural effusion and 
adhesions, severe 
extensive PP and BIP, 
synovitis, pericarditis, 
LN 
31 Gladysdale Fever, cough, dyspnea, 
tachypnea, inappetence, 
pleurodynia, weight 
loss 
died 
(Day 13) 
Pleural effusion and 
adhesions, severe 
extensive PP and BIP, 
pericarditis, LN 
32 Gladysdale Fever, cough, 
tachypnea, mild 
pleurodynia 
survived Focal extensive PP 
and BIP, sequestrum, 
LN 
34 Gladysdale Fever, tachypnea survived Mild focal PP 
35 Gladysdale Fever, cough, 
tachypnea, mild 
pleurodynia 
survived Focal extensive PP 
and BIP, sequestrum, 
LN 
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Figure 3.  Endoscopy, Ondangwa, Day 3 post-infection. Endoscopic view of a right 
caudodorsal bronchus.  Note the foamy mucus in the foreground and thicker secretions 
deeper in the bronchus. 
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Figure 4. Endoscopy, Ondangwa, Day 22 post-infection. Right caudodorsal lung.  
Minimal exudate is visible on the ventral surface of this bronchus. 
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Figure 5.  Endoscopy, Ondangwa, Day 29 post-infection.  Right caudodorsal lung.  A 
small amount of exudate remains visible in the bronchi. 
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with CBPP were seen in either the Ondangwa or Shawawa groups.  Endoscopic views of 
the affected areas of lung in all three groups of cattle revealed minimal evidence of lung 
pathology; only mild increases in lung secretions were seen post-inoculation (Figures 3-
5). 
Gross pathology.  Two animals infected with strain Gladysdale were euthanized 
when they became moribund.  These animals demonstrated severe unilateral pleural 
effusion; severe, locally extensive unilateral, chronic, fibrinous pleural pneumonia; and 
moderate, multifocal, coalescing bronchopneumonia with fibrinoeffusive, proliferative 
pleuritis (Figure 6). These two animals also showed moderate, subacute, pericardial 
effusion; marked, interstitial peritracheal, perivascular, mediastinal and sternal edema; 
and marked lymphadenomegaly and edema of the tracheobronchial lymph nodes.  One of 
these cattle also showed moderate, diffuse, subacute, fibrinous synovitis and 
fibrinohemorrhagic and necrotic tenosynovitis of the right rear tibiotarsal joint (Figure 
7). 
The three Gladysdale-infected cattle that were euthanized on Day 36 post-
inoculation had varying degrees of pulmonary lesions.  Two cattle had marked to severe 
focally extensive, caudal to caudodorsal, chronic pleuropneumonia with sequestrae and 
focal coalescing mucopurulent to caseous abcesses and severe, focally extensive, chronic, 
proliferative pleuritis (Figures 8-11).  The third animal had mild, focal, unilateral, 
chronic broncho- and interstitial pneumonia.  One animal had mild synovial proliferation 
of a tibiotarsal joint.  In all cases, CBPP lesions were on the right side of the pleural  
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Figure 6. Gladysdale, 10 days post-infection, right thoracic cavity. Severe, unilateral, 
chronic, fibrinoeffusive pleuropneumonia. Dorsal is to the left, cranial is to the top of the 
photo.  The thorax was filled with large quantities of a translucent yellow fluid containing 
strands and sheets of fibrin, the latter of which were adherent to the parietal and visceral 
pleura. In areas of the caudal dorsal lung the lobes were adherent to the diaphragm, rib 
cage and adjacent lobes of the lung. The parietal pleura was multifocally covered by a 
velvet-like, hyperemic proliferative mesothelium. 
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Figure 7. Gladysdale, 13 days post-infection, right tibiotarsal joint. Mild, diffuse, 
fibrinous arthritis/synovitis. The joint contained a watery synovial fluid with flecks and 
strands of fibrin. The synovial membranes were slightly hyperemic. 
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Figure 8. Gladysdale, 36 days post-infection, bilateral lungs and mediastinum. 
Severe, unilateral, chronic, fibrinous pleuropneumonia. The right caudal lung was 
severely enlarged, firm and covered by a sheet of fibrin. Further cranial on the right 
caudal lobe there is externally visible widening of interlobular septae (edema). The left 
lung was unaffected. Note also the the widening of the mediastinum, which was due to 
edema and a marked increase in the size of the mediastinal lymph nodes, which were 5-
10X normal in size and edematous. 
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Figure 9. Gladysdale, 36 days post-infection, right thoracic cavity. In the right caudal 
lung the interlobular septae were widened, the lung margins were rounded and the lung, 
on palpation, was firm with a palpable discrete mass. The fibrous adhesions in the cranial 
lung were evidence of past non-CBPP-associated anteroventral bronchopneumonia.   
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Figure 10. Gladysdale, 36 days post-infection, right caudal lung lobe. A mass was 
observed on cross section. The mass was well-demarcated and contained a mucopurulent 
to caseous core (abscess).  
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Figure 11. Gladysdale, 36 days post-infection, cross section of right caudal lung. 
Severe, unilateral, chronic, pleuropneumonia with sequestrum formation. In the right 
caudal lung was a well-delineated focus of sequestered lung in which the lung 
parenchyma was dark red, firm and contained foci of necrosis. In the surrounding aerated 
lung there is marked widening of interlobular septae (edema) and proliferation of fibrous 
connective tissue (marbling).  
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Table 3.  Scoring algorithm for gross and histologic lesions in infected cattle. Gross 
Pathology: Percentile of lung involvement. Histopathology: Percentile of parenchymal 
involvement in sections of representative lesions. Scoring of gross and histopathology is 
based on degree of severity. This is generally a matter of % of parenchymal involvement 
and is a subjective score. The pathology (distribution, duration, infiltrate/exudate) is 
consistent in most cases. 
 
Gross 
Pathology 
Scores 
Score Percentile   Histopathology 
Scores 
Score Percentile 
No Gross 
Lesions 
0 0  No Significant 
Lesions 
0 0 
Minimal 1 <5  Minimal 1 <5 
Mild 2 5 - 10  Mild 2 5 - 10 
Moderate 3 10-25  Moderate 3 10-25 
Marked 4 25-50  Marked 4 25-50 
Severe 5 >50  Severe 5 >50 
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cavity and in the right lung, consistent with the site of inoculation.  Two animals also 
exhibited evidence of resolved anteroventral bronchopneumonia. The average gross 
pathology score for CBPP lung lesions in the Gladysdale group was 4 of 5 (Table 3), and 
1.8 of 5 for lesions of the lymph nodes.  The lymph nodes of the two nonsurviving cattle 
had an average score of 4.5 of 5 and the three surviving cattle (which were euthanized 
and necropsied more than 20 days after resolution of clinical signs) had lymph node 
scores of 0 of 5.   
Four of five cattle infected with strain Ondangwa had characteristic gross lesions 
of CBPP at necropsy on Day 42 post-infection.  All lesions attributable to CBPP were 
located in the right caudal lung at the site of inoculation.  Lesions included minimal to 
severe, focally extensive, unilateral, subacute to chronic, broncho- and interstitial 
pneumonia.  One animal had chronic pleural adhesions attributable to CBPP.  Again, 
several cattle had evidence of resolved anteroventral bronchopneumonia separate from 
any CBPP lesions, and lesions of chronic verminous pneumonia (lungworm) were also 
seen.  No animals had gross lesions of the lymph nodes, and no joint involvement was 
noted.  The average gross lung lesion score for animals infected with strain Ondangwa 
was 2.8 of 5, and the average lymph node score was 0 of 5.   
Three cattle infected with the Shawawa strain had characteristic gross CBPP 
lesions at necropsy on Day 43 post-infection, also confined to the right caudal lung.  
These lesions included minimal to mild, focal, unilateral, subacute to chronic broncho- 
and interstitial pneumonia.  No Shawawa-infected cattle had lesions of the lymph nodes 
or joints.  As in the other groups, several animals had evidence of resolved anteroventral 
  
43 
bronchopneumonia or verminous pneumonia unrelated to CBPP.  The average gross lung 
lesion score for cattle infected with strain Shawawa was 0.5 of 5 and the average lymph 
node score was 0 of 5. 
Histopathology.  Microscopic lesions of the lung in Gladysdale-infected cattle 
included marked to severe, diffuse, chronic, suppurative bronchopneumonia with 
bronchial lymphoid hyperplasia in all animals (Figures 12-21).  Lesions of the 
tracheobronchial lymph nodes ranged from mild lymphoid hyperplasia to marked, diffuse 
lymphoid hyperplasia with sinus histiocytosis and edema (Figures 22-23).  Joint lesions 
in three cattle demonstrated mild to marked diffuse, subacute, proliferative lymphocytic 
synovitis.  Two animals had no microscopic joint involvement.  The average 
histopathology lung lesion score in Gladysdale-infected cattle was 4.6 of 5 and the 
average lymph node lesion score was 3.6 of 5.  
Cattle infected with MmmSC strain Ondangwa demonstrated moderate to severe, 
focally-extensive to diffuse, chronic, suppurative interstitial and bronchopneumonia with 
bronchial lymphoid hyperplasia (Figure 24).  Lesions of the lymph nodes included 
moderate to marked diffuse, lymphoid hyperplasia of the tracheobronchial lymph nodes.  
No joint lesions were noted.  The average microscopic lung lesion score was 3.2 of 5 and 
the average lymph node score was 3.4 of 5. 
Shawawa-infected cattle had lung lesions ranging from mild, diffuse, chronic, 
bronchial associated lymphoid hyperplasia to marked, diffuse, chronic, interstitial 
pneumonia with bronchial associated lymphoid hyperplasia to severe, diffuse, chronic 
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Figure 12.  Gladysdale, 13 days post-infection, right lung. Severe, unilateral, chronic, 
lymphoproliferative bronchopneumonia.  The lamina propria-submucosa of the airways 
(bronchioles) were infiltrated by large numbers of lymphocytes and plasma cells and 
lesser numbers of macrophages and fewer neutrophils. Magnification: 400x; bar = 
150µm. 
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Figure 13. Gladysdale, 13 days post-infection, right caudal lung bronchiolitis. 
Severe, unilateral, chronic, lymphoproliferative bronchopneumonia and bronchiolitis. 
Magnification: 100x; bar = 1500 mm. 
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Figure 14. Gladysdale, 13 days post-infection, bronchus of right lung. Severe, 
unilateral, chronic, lymphoproliferative bronchopneumonia. The lamina propria-
submucosa of the airways (bronchioles) were infiltrated by large numbers of lymphocytes 
and plasma cells and lesser numbers of macrophages and fewer neutrophils. 
Magnification: 400x; bar = 150µm. 
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Figure 15. Gladysdale, 13 days post-infection, right lung bronchus. Severe, unilateral, 
chronic, lymphoproliferative bronchopneumonia/ bronchiolitis. The lamina propria-
submucosa of the airways (bronchioles) were infiltrated by large numbers of lymphocytes 
and plasma cells and lesser numbers of macrophages and fewer neutrophils. 
Magnification: 100x; bar = 1500 µm. 
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Figure 16. Gladysdale, 36 days post-infection, right lung. Severe, unilateral, chronic, 
lymphoproliferative pleuropneumonia. The visceral pleura, which was effaced and 
replaced by fibrin and fibrous connective tissue, was markedly thickened and infiltrated 
by large numbers of lymphocytes, plasma cells and lesser numbers of foamy 
macrophages and rare neutrophils. Magnification: 400x; bar = 150 µm. 
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Figure 17. Gladysdale, 36 days post-infection, right lung, lymphoproliferation. 
Severe, unilateral, chronic, proliferative pleuropneumonia. Magnification: 1000x; bar = 
25 µm. 
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Figure 18. Gladysdale, 36 days post-infection, pleura of right lung.  Severe, unilateral, 
chronic, lymphoproliferative pleuropneumonia. The visceral pleura was effaced and 
replaced by fibrous connective tissue, and was markedly thickened and infiltrated by 
large numbers of lymphocytes, plasma cells, foamy macrophages and neutrophils. 
Magnification: 1000x; bar = 25 µm. 
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Figure 19. Gladysdale, 36 days post-infection, right lung lymphoid follicle. The lung 
was replaced with massive interlobular fibrosis with lymphoid proliferation and lymphoid 
follicular development. Magnification: 400x; bar = 150 µm. 
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Figure 20. Gladysdale, 36 days post-infection, right lung fibrosis. Severe, unilateral, 
chronic, fibrinoproliferative pneumonia. The lung was often characterized by “marbling” 
with pronounced interlobular fibrosis with sequestration of pulmonary tissues 
accompanied by lymphoid proliferation with follicular development. Magnification: 40x; 
bar = 1000 µm. 
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Figure 21.  Gladysdale, 36 days post-infection, right lung, fibrous connective tissue. 
Massive dense interlobular fibrosis occurred, sequestering pulmonary tissue. 
Magnification: 400x; bar = 150 µm. 
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Figure 22.  Gladysdale, 13 days post-infection, tracheobronchial lymph node. 
Lymphoid germinal centers with expanding mantles were markedly increased in number, 
indicative of an expansion of the B cell compartment.  Magnification: 100x; bar = 1500 
µm. 
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Figure 23.  Gladysdale, 13 days post-infection, lymph node germinal center. 
This tracheobronchial lymph node showed a germinal center containing extensive 
evidence of apoptosis of lymphoblastoid cells.  Magnification: 400x; bar = 150 µm. 
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Figure 24. Ondangwa, 42 days post-infection, pneumonia of right lung. Subacute 
sero-fibrinous pneumonia, necrosuppurative and edematous.  Magnification: 40x; bar = 
1000 µm. 
  
57 
bronchiolitis obliterans with severe bronchial associated lymphoid hyperplasia (Figure 
25).  Lesions of the lymph nodes in this group were moderate to marked with lymphoid 
hyperplasia of the tracheobronchial lymph nodes.  No joint lesions were noted.  The 
average microscopic lung lesion score in this group was 2.6 of 5 and the average lymph 
node score was also 2.6 of 5.   
Transmission electron microscopy.  TEM was successful only on Gladysdale 
animals at necropsy.  Samples taken via bronchial biopsy contained excessive crush 
artifact.  Images of the bronchial tissues collected at necropsy showed the mycoplasma 
present in large numbers on the epithelial surface, but none were seen within the 
epithelial cells (Figure 26).  Mycoplasmas were present in high concentrations at the 
base of the cilia of respiratory epithelial cells. 
 Serology. All animals infected with strains Ondangwa and Shawawa were 
negative via the complement fixation test at Days 0, 24 and 42 post-infection.  
 
DISCUSSION 
One isolate (Gladysdale) used in this study was selected as it was known to 
produce severe acute pulmonary disease in Bos taurus cattle.  The Ondangwa and 
Shawawa isolates were African field strains known to produce moderate-to-severe 
disease in Bos indicus cattle.  We anticipated a varied spectrum of disease in each 
experimental group.  The clinical results supported the selection of these strains to 
produce the desired models, as Gladysdale-infected cattle showed significantly more  
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Figure 25. Shawawa, 43 days post-infection, right lung. Chronic fibrinoeffusive 
pneumonia with thickened alveolar septae and intra-alveolar lymphocytes and 
macrophages.  Magnification: 1000x; bar = 25 µm. 
  
59 
 
Figure 26.  Gladysdale, 36 days post-infection, transmission electron microscopy. 
A natural killer cell adjacent to mycoplasma among the cilia of a bronchial epithelial cell.  
Magnification: 14,800X; bar = 2 µm.
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severe clinical signs of disease than did Ondangwa or Shawawa-infected animals.  While 
the number of animals used was small, the results support previous reports as far as the 
percentage of animals demonstrating clinical recovery that still had lesions at necropsy17. 
 The onset of clinical disease was rapid in all models compared to natural 
infection, with the first clinical signs appearing as soon as Day 3 post-inoculation.  The 
incubation period of naturally-occurring disease varies between 5-207 days, but is 
normally between 31-45 days17. Animals infected with strain Gladysdale showed 
significantly more severe clinical disease than did animals infected with either of the two 
African field strains, and onset of characteristic clinical signs was faster by 3-4 days in 
Gladysdale-infected animals.  Gladysdale-infected cattle also demonstrated higher rectal 
temperatures, with all animals but one reaching >105oC within nine days of inoculation.  
In comparison, one each of Ondangwa and Shawawa-infected animals reached a 
maximum of 103.6oC, only a mild febrile response.  The other Ondangwa- and Shawawa-
infected cattle remained afebrile, although as temperatures were taken only once daily a 
rapidly-spiking and resolving fever could not be ruled out.  Fever is an unreliable 
indicator of infection, however, as demonstrated by the three Ondangwa and two 
Shawawa animals without detectable fever that nonetheless had gross necropsy lesions of 
CBPP.   
All Gladysdale-infected cattle but one developed cough between Days 7-10 of 
infection, and the cough generally lasted less than a week.  Three Ondangwa animals 
showed coughing lasting 5-7 days.  Only a single Shawawa animal developed a cough, 
which was evident for only 4 days.  Cough would appear to be an inconsistent clinical 
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sign, as animals without noticeable cough had lesions of moderate to severe disease at 
necropsy.  Increased respiratory rate was present in most animals starting within the first 
week post-infection, but no appreciable difference was noted between groups.   
The spectrum of gross necropsy lesions differed between groups of cattle, with 
the two Gladysdale-infected cattle requiring early euthanasia demonstrating profound 
pleural effusion and fibrin formation in addition to extensive lung involvement.  The 
three Gladysdale-infected animals that survived until the end of the experiment had 
minimal pleural effusion despite two having demonstrated mild pleurodynia earlier in the 
course of infection.  As neither ultrasound examination of the thorax or thoracocentesis 
was done, it is unknown whether these animals had pleural effusion earlier in the course 
of infection that had resolved by the time of necropsy.  Two of these three Gladysdale-
infected cattle did develop sequestrae encapsulated with a thick fibrous layer after only 
36 days of infection.  In contrast, Ondangwa- and Shawawa-infected cattle failed to 
develop classical sequestrae after 42 days of infection despite demonstrating other gross 
lesions consistent with CBPP.  It is unknown whether Ondangwa- or Shawawa-infected 
animals would develop sequestrae given a longer time course, as neither of these strains 
had been evaluated previously under controlled conditions and no published reports of 
the natural outbreaks involving these isolates exist.  The apparent failure of Ondangwa- 
and Shawawa-infected cattle to form sequestrae is apparently related to their virulence.  
No reports exist comparing long-term shedding of MmmSC in cattle infected with 
sequestra-forming or putatively non-sequestra-forming strains.  In fact, very little is 
known regarding the kinetics of long-term shedding of any isolate of MmmSC as most 
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experiments, like this study, were either short-term or did not evaluate mycoplasmal 
shedding in the long term53,65,69,97. 
Histopathology of lesions from infected animals had the full spectrum of CBPP 
lesions.  Microscopic lung lesions from Ondangwa- and Shawawa-infected animals were 
often quite similar to those from Gladysdale-infected cattle, but the percentage of 
affected lung was less.  All cattle with CBPP lesions, regardless of strain, demonstrated 
chronic interstitial and suppurative bronchopneumonia with fibrosis.  Lung tissue, 
particularly the airway submucosa, had profound infiltration of lymphocytes and plasma 
cells with fewer macrophages and occasional neutrophils.  Differences between strains 
were mostly evident as percentage of parenchymal involvement in the lesions evaluated. 
Virulence between strains appeared to be related to the amount of lung parenchyma each 
isolate was able to influence rather than the degree of lesions within the affected 
parenchyma. Notably, Gladysdale-infected cattle had a greater degree of fibrosis and 
bronchial lymphoid hyperplasia than did either Ondangwa- or Shawawa-infected cattle, 
with development of lymphoid follicles within lung parenchyma.  The increased fibrosis 
in Gladysdale-infected animals may reflect that strain’s tendency to create sequestrae, 
while strains Ondangwa and Shawawa were unable to elicit the same response in the host 
and did not form sequestrae.   
Lesions of the tracheobronchial lymph nodes varied between strains, with 
Gladysdale-infected cattle demonstrating marked lymphoid hyperplasia, edema, and sinus 
histiocytosis.  Lymph node germinal centers in Gladysdale-infected animals that 
succumbed to CBPP had numerous apoptotic lymphoblastoid cells that were not seen in 
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Gladysdale-infected animals that survived infection or in Ondangwa- or Shawawa-
infected animals.  Cattle infected with Ondangwa and Shawawa had less prominent 
lymphoid hyperplasia of tracheobronchial lymph nodes, and edema was absent.   
Only Gladysdale-infected cattle had microscopic joint lesions of lymphocytic 
synovitis, and two of the three cattle with joint lesions were the animals euthanized early 
in the experiment.  Two animals with microscopic synovitis had never been noted to be 
lame or to have clinical joint effusion.  One animal had histologic evidence of synovitis at 
Day 36 necropsy, long after all clinical signs of disease had resolved.  No joint lesions 
were seen in either Ondangwa- or Shawawa-infected cattle; it is undetermined if lesions 
might have been present earlier in infection but resolved by Day 42 necropsy. 
Transmission electron microscopy of bronchial biopsies taken during weekly 
sampling was unsuccessful due to excessive crush artifact of the tissue.  Images taken 
from necropsy tissue demonstrated large numbers of mycoplasma colonizing the surface 
of respiratory epithelial tissue, often predominantly at the base of the cilia.  These images 
do not show any evidence of intracellular MmmSC, but the intimacy of contact between 
the mycoplasma and the epithelial cell could not be definitively determined.  Most 
mycoplasma remain extracellular when infecting a host animal, but certain species are 
capable of invasion and intracellular survival in non-phagocytic cells.  The most-studied 
member of this class is M. penetrans, but M. fermentans, M. pneumoniae, M. genitalium 
and M. gallisepticum have all been shown to survive intracellularly under some 
conditions98.  Mycoplasma penetrans has been shown to have fibronectin-binding 
ability99 and to alter the host cell cytoskeleton100, both characteristics of invasive bacteria.  
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Other mycoplasma, most notably M. fermentans, are attributed to have the ability to fuse 
with the host cell.  This property is apparently dependent on the unesterified cholesterol 
content of the mycoplasma cell membrane101.  No information has been published on 
whether MmmSC possesses fusogenic capability, although M. capricolum, also within 
the mycoides cluster, is known to be fusogenic101. 
The negative results of the complement fixation test on the Ondangwa and 
Shawawa animals at Days 24 and 42, conducted by the official United States testing 
laboratory of the USDA Animal and Plant Health Inspection Service, serve to underline 
the weaknesses of that test.  The CFT is reported to detect only approximately 70% of 
chronic cases of CBPP and often fails to detect asymptomatic animals early in the course 
of infection4.  Despite direct inoculation of the organism into the lung and evidence of 
successful infection in the form of fever in several animals, the CFT remained uniformly 
negative in all Ondangwa and Shawawa animals including those shown to have CBPP at 
necropsy.  The CFT is recommended as a herd level test102, so the small numbers of 
animals in our experimental groups may have decreased test sensitivity.  Nonetheless, the 
CFT is currently the official standard for determining infection per the OIE88,103, and 
further evidence of its drawbacks only underlines the need for more sensitive and specific 
diagnostic options. 
Currently, feedlot veterinarians and animal producers in the United States are 
becoming concerned about the increasing incidence and severity of Mycoplasma bovis 
pneumonia in feedlot cattle (reported at the 2007 annual Forum of the American College 
of Veterinary Internal Medicine).  In addition, these veterinarians have warned about the 
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potential for reintroduction of CBPP into the United States and have expressed concern 
that belated recognition of this disease would occur, in part because of the similarity 
between lesions of CBPP and severe M. bovis pneumonia104-108.  Cattle shipping and 
feedlot management practices in the United States would provide a fertile ground for 
rapid transmission of CBPP, whether accidental or deliberate, and delays in diagnosis 
would prove extremely costly.  This underscores the need for further study of CBPP and 
development of additional means of both diagnosis and differentiation from M. bovis.  
Better understanding of the mechanisms by which MmmSC causes disease may 
indirectly provide clues for the management of M. bovis pneumonia as well. 
In conclusion, direct endobronchial inoculation of 1010 MmmSC without 
adjuvants appears to be a reliable and repeatable model of CBPP infection.  We validated 
this model using three African/Australian cluster strains of MmmSC reported to have 
differing virulence.  Two of these strains, Ondangwa and Shawawa, have not previously 
been evaluated in experimental models.  Results from this model support descriptions of 
the relative virulence of natural infections involving these isolates: Gladysdale exhibited 
the greatest virulence, followed by Ondangwa, and Shawawa demonstrated the lowest 
virulence.  Using this infection model, this study generated an acute severe disease group 
(Gladysdale) and two chronic inapparent disease groups of differing severity (Ondangwa 
and Shawawa).  Morbidity and incidence of necropsy lesions for each inoculated strain 
were comparable to reports of naturally-occurring disease.  The model produced lower 
mortality rates than those reported in natural infections of each isolate, although the 
number of cattle infected with each isolate was small.  Lack of mortality in the 
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Ondangwa- and Shawawa-infected groups as compared to natural outbreaks may be due 
to differences in susceptibility between Bos taurus and Bos indicus cattle. 
Advantages of endobronchial inoculation include a known site of infection within 
the lung which may be repeatedly sampled as needed, and relatively atraumatic lower 
respiratory tract sampling in standing cattle.  Disease onset was more rapid than for in-
contact infection, compressing the required number of sampling days and allowing all 
cattle to be sampled as a cohort with a defined time since infection.  This model is also 
adaptable to field conditions: although a videoendoscope was used in this study, a 
portable light source and visual (rather than video) confirmation of endoscope placement 
would be equally effective.  However, either sampling method requires at least 3 
personnel and a means of cattle restraint such as a chute and headgate.  Other 
disadvantages of this model include expensive endoscope equipment requirements, 
fragility of equipment, and labor.   
Standardization of inoculum size and placement, time since infection and 
infection site in experimental cattle should remove much of the uncertainty present in the 
studies of natural or experimental in-contact CBPP infections.  MmmSC strain 
differences may be more readily determined without the confounding factors of unknown 
bacterial dose and indeterminate time since infection.  The development of these three 
side-by-side CBPP models of differing virulence will also permit more direct comparison 
of host effects versus inoculum effects, as the model, using any of the tested strains, 
could be applied to discrete subgroups of cattle segregated by species, breed or BoLA 
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type. This model and the data presented here should facilitate future study of MmmSC 
strains exhibiting differential virulence. 
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CHAPTER III 
 
TEMPORAL GLOBAL GENE EXPRESSION PROFILES OF CATTLE 
INFECTED WITH MYCOPLASMA MYCOIDES MYCOIDES SMALL COLONY 
 
INTRODUCTION 
Little is known about the interactions of MmmSC with the bovine host.  Previous 
studies have focused on particular aspects of the immune system53,65-67,97, and have 
primarily measured soluble cytokines. A significant proportion of the published studies 
on CBPP have used ex vivo or in vitro models, which likely do not duplicate the 
complexity of the interactions in the host animal.  It is known that MmmSC causes 
mycoplasmemia, indicating its global effects in the host.  The clinical signs in infected 
cattle, along with the previously published studies, support the intense involvement of the 
immune system in this disease53,65,69,97.  The normal manner of infection is direct contact, 
with the respiratory system being the route of infection4.  This study will investigate the 
temporal gene expression profiles in several respiratory-associated tissue types of cattle 
infected with CBPP.  The working hypothesis is that there will be differential gene 
expression of multiple genes and associated cellular pathways between unexposed and 
challenge infected cattle at several time points post-infection.  Analysis of the global host 
transcriptome will identify differentially-expressed genes as targets for later experiments 
and potentially provide insight into the manner in which MmmSC interacts with the host 
animal. This study holds the possibility of the identification of possible targets for 
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continued investigation of the host immune response.  This research is unique in that no 
published studies exist investigating the in vivo host gene expression of cattle with CBPP. 
 
MATERIALS AND METHODS 
Animals, isolates, route of infection and sampling procedures. Animals, route 
of infection and endoscopic sampling procedures were described in detail in Chapter II. 
This experiment was conducted only with MmmSC strain Gladysdale (APHIS). 
Isolation of total RNA from bronchoalveolar lavage fluid.  BAL fluid was 
aliquoted into microcentrifuge tubes immediately after collection and centrifuged at room 
temperature and 12,000 x g for 10 minutes.  Supernatant was discarded and pellets 
resuspended in 2ml RNAlater (Ambion).  Tubes were stored at 4ºC until further 
processing. For RNA extraction, pellets were centrifuged at 12,000 x g for 10 minutes at 
4ºC and the supernatant was discarded.  Pellets were resuspended in 1ml Tri-reagent 
(Molecular Research), and RNA extracted per manufacturer’s instructions.  The resultant 
RNA pellet was re-suspended in nuclease-free water (Ambion). Contaminant genomic 
DNA was removed by RNase-free DNase I treatment (Ambion) according to the 
manufacturer’s instructions, and samples were stored at -80ºC until used. RNA 
concentration was determined via NanoDrop® ND-1000 (NanoDrop) spectrophotometry. 
Isolation of RNA from bronchial biopsies. Two 2.5mm biopsy samples were 
obtained via endoscopic biopsy forceps from a bronchial bifurcation deep in the right 
caudal lung near the site of inoculation. The samples were placed into RNAlater and 
stored at 4ºC until processing.  During processing, biopsies were minced into small pieces 
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with a sterile scalpel, and placed in Tri-Reagent (2 biopsy samples / 1 ml of reagent) and 
further homogenized with a tissue grinder. RNA was extracted according to the Tri-
Reagent manufacturer’s instructions. The resultant RNA pellet was re-suspended in 
nuclease-free water (Ambion). Contaminant genomic DNA was removed by RNase-free 
DNase I treatment (Ambion) according to the manufacturer’s instructions, and samples 
were stored at -80ºC until used. RNA concentration was determined via NanoDrop® ND-
1000 (NanoDrop) spectrophotometry. 
Isolation of RNA from nasal cytology brushes.  Cytology brushes were 
amputated into a microcentrifuge tube containing 2ml RNAlater immediately after 
collection and stored at 4C until further processing.  Brushes were scraped into the 
RNAlater using a sterile scalpel blade, then the tube was centrifuged at 12,000 x g for 10 
minutes at 4ºC.  The supernatant was discarded and the pellet resuspended in 1ml Tri-
Reagent.  Processing continued as described above. 
RNA isolation from whole blood.  Ten milliliters of whole blood was collected 
into a syringe, then the needle removed and the blood added to a conical tube containing 
30ml Tri-Reagent BD (Molecular Research) and mixed thoroughly.  Blood was stored at 
4ºC until further processing.  RNA was extracted according to the manufacturer’s 
protocol, and processing continued as described above. 
Preparation of bovine reference RNA. Total RNA was isolated from Madin- 
Darby bovine kidney (MDBK) and bovine B lymphocyte (BL-3) cell lines (ATCC) and 
fresh bovine brain using the Tri-Reagent protocol. Cell lines were grown in 150 cm2 cell 
culture flasks with minimum essential medium Eagle (MEME) (ATCC) supplemented 
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with 10% heat-inactivated fetal bovine serum. Bovine brain was harvested from the 
cortex and cerebellum of a Holstein male calf immediately after euthanasia. The tissue 
was homogenized in ice-cold Tri-Reagent. The RNA from each sample was quantitated 
and bioanalyzed before and after pooling the samples. Total RNA isolated from three 
samples was pooled together in equal amounts, aliquoted and stored at -80ºC until 
needed. 
Construction of cDNA microarrays and annotation. Selective unique 70-mer 
oligonucleotide sets representing 13,257 cattle ORFs were obtained from normalized and 
subtracted cattle placenta and spleen cDNA libraries and based upon the earlier cDNA 
array platform GPL2864 (70) and subtracted cDNA libraries created from embryonic 
(Day 36 and Day 64) and extra-embryonic (Day 14 to 25) tissues (NCBI libraries 15993, 
15993 and 17188). Positive controls included beta actin (ACTB), glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH), and hypoxanthine phosphoribosyltransferase 
(HPRT). Exogenous spiking controls were the soybean genes chlorophyll ab binding 
protein (CAB), Rubisco small chain 1 (RBS1), and major latex protein (MSG). Negative 
controls were Cot1 DNA, genomic DNA, spotting buffer, poly-A, and water. All 70-mer 
oligos were printed in 150 mM phosphate buffer at 20 uM concentration in duplicate on 
aminosilane-coated glass slides at the W. M. Keck Center (Dr. Harris Lewin, University 
of Illinois at Urbana-Champaign). The oligos were annotated based on the GenBank 
accession number, when available. 
Sample preparation and array hybridization.  Prior to hybridization, the 
microarrays were denatured by steam exposure and UV cross-linked.  Microarrays were 
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pre-treated by washing in 0.2% SDS, followed by 3 washes in distilled water and 
immersion in prehybridization buffer [5X SSC, 0.1% SDS; 1% BSA in 100ml of water] 
at 42ºC for at least 45 minutes. Immediately before hybridization, the slides were washed 
4 times in distilled water, dipped in 100% isopropanol and dried by centrifugation. The 
labeling and hybridization procedures for host samples were an adaptation of the protocol 
developed by The Institute for Genomic Research 109. Briefly, 10 g of total RNA were 
reverse transcribed overnight to aminoallyl cDNA using 6 µg of random hexamer primers 
(Invitrogen), 0.6 l 50X dNTPs (Invitrogen) / aa-dUTP (Ambion) mix (2:3 aa- dUTP: 
dTTP) and 400U Superscript III (Invitrogen). The reaction was stopped by incubating the 
samples with 1M NaOH at 65ºC for 15 minutes and neutralized by adding 1M HCl. 
Unincorporated aa-dUTPs and free amines were removed by column passage (Qiagen) 
and dried using a speedvac. Dried samples were re-hydrated in 0.1M Na2CO3 buffer (pH 
9.0) and labeled with Cy3-ester (reference RNA) or Cy5-ester (experimental RNA) 
(Amersham Pharmacia Biosciences). After one hour of incubation in the dark at room 
temperature, uncoupled dye was removed using columns (Qiagen) and dye incorporation 
calculated via NanoDrop spectrophotometry.  The dried, labeled cDNA samples from 
experimental RNA and bovine reference RNA were resuspended in 20 l of nuclease-free 
water, mixed, and heated at 95ºC for 10 min followed by 10 min at 60ºC and another 10 
min at 25ºC. Samples were kept at 42ºC until hybridization. Following incubation at 42ºC 
and immediately before hybridization, 40 l of 2X formamide-based hybridization buffer 
were added to each sample. The samples were then hybridized to the custom bovine oligo 
array. Slides were hybridized at 42ºC for ~42 hours in a dark, humid chamber (Corning), 
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then washed for 10 min at 42ºC with low stringency buffer [1X SSC, 0.2% SDS] 
followed by two 5-minute washes in a higher stringency buffer [0.1X SSC, 0.2% SDS 
and 0.1X SSC] at room temperature with agitation. Slides were dried by centrifugation at 
800 X g for 2 min and immediately scanned.  
Data acquisition and microarray data analysis. Immediately after washing, the 
slides were scanned using a commercial laser scanner (GenePix 4000B). The genes 
represented as spots on the arrays were adjusted for background and normalized to 
internal controls using image analysis software (GenePixPro 6.0). Genes with fluorescent 
signal values below background were disregarded in all analyses. Initially, arrays were 
normalized against bovine reference RNA. The resulting data was analyzed using 
Seralogix’s suite of gene expression analysis and modeling tools (Dr. Kenneth Drake, 
www.seralogix.com). Genes were determined to be significantly differentially- expressed 
based on Seralogix’s Bayesian z-score method. Using this method genes are ranked and 
ordered according to their expression magnitudes and gene variance is computed using a 
Bayesian predicted variance value. The Bayesian variance is determined by using a 
sliding window algorithm that averages 50 variances directly on the ascending and 
descending ordered sides of each gene of interest. This method is used to smooth the 
variances across the dynamic range of intensity values. Significantly changed genes were 
determined with the Bayesian z-test (p < 0.0125).  New computational tools developed by 
Seralogix were used for the identification of Biosignature Dynamic Bayesian Network 
modeling, mechanistic gene discovery and pattern/pathway recognition. Seralogix’s 
Biosignature Analysis Framework is comprised of an integrated suite of software tools 
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(XManager, XConsole & XBuilder) and relational database storage specialized for 
management and analysis of biosignature data. 
Validation of microarray results. Sixteen randomly-selected bovine genes with 
differential expression on microarray were analyzed by quantitative RT-PCR (qRT-PCR). 
Two micrograms of RNA from the same samples used for microarray hybridization were 
reverse transcribed into cDNA using TaqMan (Applied Biosystems). For relative 
quantitation of target cDNA, samples were run in individual tubes in a SmartCycler I 
(Cepheid). One SmartMix bead (Cepheid) was used for 2 x 25 l PCR reactions along 
with 20 ng of cDNA, 0.2X SYBR Green I dye (Invitrogen) and 0.3 M forward and 
reverse primers (Sigma Genosys) designed by Primer Express Software v2.0 (Applied 
Biosystems) or Primer3Plus (www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi) (Table 3). For each gene tested, the individual 
calculated threshold cycles (Ct) were averaged among each condition and normalized to 
the Ct of the bovine β2-microglobulin gene from the same cDNA samples before 
calculating the fold change using the Ct method (Applied Biosystems Prism SDS 7700 
User Bulletin #2). For each primer pair, a negative control (water) and an RNA sample 
without reverse transcriptase (to determine genomic DNA contamination) were included 
as controls during cDNA quantitation. Because our analysis considered genes 
differentially expressed based on z-score and not on fold change, array data were 
considered valid if the fold change of each gene tested by qRT-PCR was expressed in the 
same direction as determined by microarray analysis. 
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RESULTS 
RNA isolated from all four bovine sample types (bronchoalveolar lavage fluid, 
bronchial biopsies, nasal cytology and blood) was indirectly labeled and co-hybridized 
against bovine reference RNA on a custom 13.2K bovine oligoarray at each sampling 
Day (Days preinoculation, 1, 8, 15, 22 and 29).  Bioanalysis determined that bovine 
reference RNA was of good quality (RIN = 9.7, 28S/18S ratio = 2.1, OD260/280 = 2.01, 
OD260/230 = 1.85 for reference RNA).  Bioanalysis was not available for experimental 
samples, but OD260/230 > 1.82 via spectrophotometry.  When hybridized on the arrays, the 
bovine reference RNA generated a readable signal intensity on more than 85% of the 
spots on the microarray (SNR > 3SD above background) and co-hybridization with 
experimental samples allowed comparison of bovine gene expression profiles across all 
tissue types.  Signal analysis of arrays revealed that Day 29 arrays contained an 
unacceptable signal-to-noise ratio possibly due to contamination; data from Day 29 
arrays was considered invalid and eliminated from further analysis.  Arrays from all other 
sampling days contained usable data.   
Dynamic Bayesian modeling analysis of microarray results.  We conducted an 
in silico predictive mathematical model using the host gene expression data to identify 
genes, gene processes and pathways important in the pathogenesis of CBPP. Specific 
genes and pathways are presented below for each tissue type assayed, including genes 
identified as mechanistic.  A mechanistic gene is a gene which has the most 
influence/impact within its dynamic Bayesian network model in comparison to the 
control or other condition.  The implication of a mechanistic gene is that it may be a 
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candidate for being a major player in the disease, and it is being temporally modulated 
significantly differently from the control.  Mechanistic genes do not necessarily undergo 
a large fold change; a small fold change in a mechanistic gene may yield much greater 
changes in downstream genes.  Where Gene Ontology (GO) pathways are discussed, Bos 
taurus (bta) pathways are referenced.  Where KEGG pathways are discussed, human 
(hsa) pathways are used instead of the bovine (bta) pathways due to completeness and 
annotation. 
Bronchoalveolar lavage samples.  Microarray analysis revealed that 
approximately 984 bovine genes were detected as differentially expressed (z-score p < 
0.0125) in infected animals compared with pre-inoculation controls between 1-22 Days 
post-infection (Table 4). These genes encompassed 908 GO processes, with 43 highly-
activated processes comprised of 274 genes (Appendix A) (processes downloaded from 
Gene Ontology Consortium Database; http://www.geneontology.org).  One hundred 
twenty-five mechanistic genes were identified in this comparison (Appendix B).  The 
overall expression profile of bronchoalveolar lavage fluid was one of upregulation, as 
upregulated genes outnumbered downregulated ones by a ratio of 2:1.   Samples were 
also obtained on Day 29, but a low signal-to-noise ratio on Day 29 arrays prohibited the 
use of that data. 
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Table 4. BAL gene expression. Numbers of genes differentially expressed in bovine 
bronchoalveolar lavage fluid from 1-22 days post-infection with MmmSC. 
 
Time Point (Day) # Genes 
upregulated 
# Genes 
downregulated 
Total # Genes 
differentially 
expressed 
1 201 41 252 
8 201 87 288 
15 149 58 207 
22 163 74 237 
 
 
 The greatest number of transcriptional changes occurred in the bta GO groups 
chemokine activity, negative regulation of cell proliferation, viral genome regulation, 
defense response, sugar binding, and humoral immune response.  All of these processes 
were highly active early in infection (Day 1) and decreased in activity later in infection. 
Top-ranked KEGG pathways in BAL samples included cytokine-cytokine 
interaction (hsa04060), lectin-induced complement pathway (hsa99020), apoptosis 
(hsa04210), androgen and estrogen metabolism (hsa00150), Toll-like receptor signaling 
(hsa04620), antigen processing and presentation (hsa04612), and T-cell receptor 
signaling (hsa04660) (Appendix C).  The cytokine-cytokine interaction pathway was 
upregulated.  Genes CCL2, IL8, IL1A and IL1B all had moderate to high upregulation at 
all time points.  These genes, plus IL8RB, were all found to be mechanistic; 81 of 235 
genes in the pathway were assessed.  Two of 9 genes of the lectin-induced complement 
pathway were measured and C2 was upregulated with moderate downregulation of C4A.  
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Both of these genes were found to be mechanistic.  Twenty-seven of 56 genes of the 
apoptosis pathway were interrogated.  This pathway was upregulated at Day 1, but Day 8 
onward revealed down regulation of MYD88.  Two genes were found to be mechanistic: 
IL1B and NFKBIA.  None of 18 genes of the androgen and estrogen receptor pathway 
were assayed.  Pathway intermediates HSD11B1 and HSD11B2 were downregulated at 
all time points, but CYP11B1 was strongly upregulated at all time points.  Both 
CYP11B1 and HSD11B1 were identified as mechanistic genes.  The Toll-like receptor 
signaling pathway was primarily upregulated at all time points with 38 of 65 pathway 
genes assayed.  The exception to the upregulation was IL6, which was either 
downregulated or had no change from baseline at all time points.  IL12A was 
downregulated on Day 22.  Mechanistic genes in the TLR pathway included TLR3, 
NFKB1, NFKBIA, IL1B, IL6 and IL8.  The antigen processing and presentation pathway 
had a pattern of slight upregulation early in infection, which changed to slight 
downregulation by Day 15.  Eleven of the 18 TLR pathway genes were investigated.  
Mechanistic genes identified in this pathway were PSME1, TAPBP, Tap2 and PSME2.  
The T cell receptor signaling pathway was investigated by measuring 21 of 49 pathway 
genes, and the pattern was again one of upregulation at all time points.  Four mechanistic 
genes were identified including PTPN6, IKBKG, NFKB1 and NFKBIA. 
Bronchial biopsy samples.  Microarray analysis revealed that approximately 
3218 bovine genes were detected as differentially expressed (z-score p < 0.0125) in 
infected animals compared with pre-inoculation controls between 1-22 Days post-
infection (Table 5). These genes encompassed 908 GO processes, with 49 highly-
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activated processes comprised of 518 genes (Appendix D).  Three hundred fifty-six 
mechanistic genes were identified in this comparison (Appendix E).  The overall 
expression profile of bronchial biopsy samples was one of downregulation, with 
downregulated genes outnumbering upregulated ones by a ratio of 1.5:1 to 4:1 at time 
points from days 1-22.  
 
Table 5. Bronchial biopsy gene expression. Numbers of genes differentially-expressed 
in bovine bronchial biopsies from 1-22 days post-infection with MmmSC. 
Time Point (Day) # Genes 
upregulated 
# Genes 
downregulated 
Total # Genes 
differentially 
expressed 
1 591 2384 2975 
8 951 1651 2602 
15 1185 1227 2412 
22 1023 2173 3196 
 
 
 The most transcriptional changes occurred in bta GO processes extracellular 
matrix structural constituent, protein transporter activity, protein secretion, collagen 
catabolism and metalloendopeptidase activity.  The extracellular matrix structural 
constituent process was most active starting at Day 8, while the protein processes were 
most active on Day 1.  Collagen catabolism increased slightly over time, while 
metalloendopeptidase activity was relatively constant post-infection.  
In bronchial biopsy samples, the top five ranked KEGG pathways were oxidative 
phosphorylation (hsa00190), lectin-induced complement pathway (hsa99020), natural 
  
80 
killer cell mediated cytotoxicity (hsa04650), glutathione metabolism (hsa00480), and 
prostaglandin and leukotriene metabolism (hsa00590) (Appendix F).  Seventy-five of 
152 oxidative phosphorylation genes were assayed, revealing prominent downregulation 
with the exception being COX7B.  No mechanistic genes were identified from this 
pathway.  Two of 9 lectin-induced complement pathway genes were assayed, disclosing 
downregulation of C4A.  C2 was downregulated in early infection but was upregulated 
from Day 15 onward, and both genes were found to be mechanistic.  Thirty-two of 73 
natural killer cell mediated cytotoxicity pathway genes were assayed.  The pattern was 
mostly one of downregulation, with only genes RAC1, RRAS, FYN and TNFRSF6 
having upregulation at any time point.  Sixteen mechanistic genes were discovered, 
including MAPK1, FYN, several subunits of PIK3, ICAM1, ITGAL, TNFRSF6, RAC1 
and SYK. 
Nasal cytology samples. Microarray analysis revealed that approximately 2043 
bovine genes were detected as differentially expressed (z-score p < 0.0125) in infected 
animals compared with pre-inoculation controls between 1-22 days post-infection (Table 
6). These genes encompassed 908 GO processes, with 45 highly-activated processes 
comprised of 329 genes (Appendix G).  One hundred seventy-six mechanistic genes 
were identified in this comparison (Appendix H).  In cytology samples, the gene 
expression profile varied widely by time point.  Initially upregulation was dominant, but 
downregulated genes were more prevalent at Day 8.  The profile returned to one of 
upregulation from Days 15-22. 
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Table 6. Nasal cytology gene expression. Numbers of genes differentially expressed in 
bovine nasal cytology samples from 1-22 days post-infection with MmmSC. 
Time Point (Day) # Genes 
upregulated 
# Genes 
downregulated 
Total # Genes 
differentially 
expressed 
1 827 252 1079 
8 493 764 1257 
15 525 414 939 
22 467 222 689 
 
 
 The bta GO processes demonstrating the largest number of transcriptional 
changes were T-cell receptor complex, mitosis, myogenesis, microtubule associated 
complex and oxygen and reactive oxygen species metabolism.  Most of these processes 
were relatively constant over time post-infection.  The T-cell receptor complex process 
had high activity on Day 1 followed by a decrease on Day 8 and a gradual increase 
thereafter. 
The top five KEGG pathways for cytology samples included glycerolipid 
metabolism (hsa00561), oxidative phosphorylation (hsa00190), CD-40L signaling 
pathway (hsa99110), TGF-beta signaling pathway (hsa04350), and epithelial cell 
signaling in Helicobacter pylori infection (hsa05120)(Appendix I).  Sixteen of 30 
glycerolipid metabolism pathway genes were analyzed which had a predominant pattern 
of downregulation at all time points.  The exception was gene YWHAZ, which was 
upregulated throughout.  Five mechanistic genes were identified: PCAF, PLA2G1B, 
PPAP2C, YWHAZ and AGPAT1.  Seventy-five of 152 genes of the oxidative 
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phosphorylation pathway were analyzed and were primarily downregulated, but in this 
tissue several of the COX subunits were upregulated.  Three mechanistic genes were 
identified: ATP5A1, ATP5F1 and ATP5G2.  Seven of thirteen genes in the CD-40L 
signaling pathway were investigated, revealing that the pathway was upregulated on Day 
1 but downregulated later in infection; however, gene CHUK was consistently 
upregulated and gene IKBKB was consistently downregulated.  Three mechanistic genes 
were identified: TNFRSF5, IKBKB and CHUK.  Twenty-five of 43 genes of the TGFβ 
signaling pathway were evaluated.  The pathway appeared to be upregulated at Day 1, but 
many genes were downregulated thereafter; genes ID1 and ID3 remained upregulated at 
all time points.  Eight mechanistic genes were identified: SMAD1, SMAD2, SMAD4, 
ID1, ID3, BMP4, AMH and BMPR1A.  Eleven of 25 genes of the epithelial cell 
signaling in H. pylori infection pathway were assayed.  The pathway was upregulated at 
Day 1, with genes CHUK and CCL5 remaining upregulated.  Genes NFKBIA and 
NFKB1 were downregulated from Day 8 onward.  Three mechanistic genes were found: 
CCL5, CHUK and NFKB1. 
Blood samples. Microarray analysis revealed that approximately 924 bovine 
genes were detected as differentially expressed (z-score p < 0.0125) in infected animals 
compared with pre-inoculation controls between 1-22 days post-infection (Table 7). 
These genes encompassed 908 GO processes, with 49 highly-activated processes 
comprised of 327 genes (Appendix J).  One hundred five mechanistic genes were 
identified in this comparison (Appendix K).  The gene expression profile was 
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predominantly one of mild upregulation early in infection (Days 1-15), but 
downregulation predominated on Day 22.   
 
Table 7. Blood gene expression. Numbers of genes differentially-expressed in bovine 
blood from 1-22 days post-infection with MmmSC. 
Time Point (Day) # Genes 
upregulated 
# Genes 
downregulated 
Total # Genes 
differentially 
expressed 
1 180 95 275 
8 148 127 275 
15 179 81 260 
22 109 454 563 
 
 
 The bta GO processes having the greatest change in gene expression were G-
protein signaling, coupled to cAMP nucleotide second messenger, endonuclease activity, 
Ras protein signal transduction, nuclease activity and ATP-dependent RNA helicase 
activity.  The first process was relatively constant over time post-infection, while the 
others were highest on Day 1 and decreased slightly thereafter. 
 The top-scoring KEGG pathways for blood included heparan sulfate biosynthesis 
(hsa00534), chondroitin/heparan sulfate biosynthesis (hsa00532), ethylbenzene 
degradation (hsa00642), arginine and proline metabolism (hsa00330), and tyrosine 
metabolism (hsa00380) (Appendix L).  Three of 33 genes of the heparan sulfate pathway 
were evaluated and one gene, GLCE, was both strongly upregulated and mechanistic.  
Three of 8 genes of the chondroitin/heparan sulfate biosynthesis pathway were measured, 
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revealing upregulation in EXT2 and downregulation in XYLT2 and B3Gat3 at all time 
points, but only B3Gat3 was determined to be mechanistic.  Three of 38 genes of the 
ethylbenzene degradation pathway were evaluated, with downregulation occurring in all 
genes.  The gene PCAF was determined to be mechanistic.  Twenty-seven of 40 genes in 
the arginine and proline metabolism pathway were assayed, disclosing a pattern of mixed 
regulation, with many genes switching from an upregulated to downregulated state or 
vice versa during the course of infection.  The single gene identified as mechanistic was 
ARG2.   Twenty-four of 190 genes of the tyrosine metabolism pathway were assayed, 
revealing increasing upregulation over time.  Seven genes, TH, HEMK1, ADC3, TYR, 
Tat, DCT and TYRP1, were found to be mechanistic.   
Comparison of microarray and RT-PCR results.  Sixteen genes were selected 
for real-time PCR comparison with microarray results (Table 8)(Figure 26).  Genes were 
randomly selected from those determined to be mechanistic via microarray data analysis, 
so not all genes selected were differentially expressed in every tissue type or at every 
time point analyzed.  Results were considered to be in agreement if the direction of fold 
change determined via microarray (up- or downregulation) agreed with direction of fold 
change via real-time PCR.  Agreement between microarray results and RT-PCR results 
over the sixteen genes analyzed was 88% for bronchoalveolar lavage fluid, 92% for 
bronchial biopsy, 90% for nasal cytology and 89% for blood.  Agreement within time 
points of a gene was very consistent; disagreement typically included all time points of a 
given gene rather than individual time points of several genes.
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Table 8. Primers for real-time PCR analysis of bovine genes 
GenBank 
Accession # 
Gene 
Symbol 
Gene Product Forward Primer (5’-3’) Reverse Primer (5’-3’) 
NM_174093 IL1B Interleukin 1β CTTGGGTATCAAGGACAAGAATCTA TAGGGTACAGGACAGACTCAAATTC 
NM_001012671 STAT3 Signal 
transducer and 
activator of 
transcription 3 
GGATAACCTCATTAGCAGAATCTCA TAAGTTTCTAAACAGCTCCACGATT 
NM_174091 IL18 Interleukin 18 CTGTGAGAACAAAATTGTTTCCTTT TTCTGGTTTTGAACAGTGAACATTA 
NM_181003 Aqp4 Aquaporin 4 AATAGCTGATAATCAAGGGCTTTCT GTGTGATGTCTCTCTGGAACCTTAT 
NM_173877 F2 Complement 
factor 2 
GATGGAAAATATGGCTTCTACACAC AGGAACAAACCACAAAAATAATTCA 
NM_174062 FTH1 Ferritin heavy 
chain 1 
TCTTCCTTCAGGATATCAAGAAACC GAGTCTCAATGAAATCACACAGATG 
NM_174101 LGMN legumin GTATGCTTTGAGACATTTGTACGTG TCTCTGATTAGCACACATTGTAAGG 
NM_175793 MAPK1 mitogen-
activated protein 
kinase 1 
GGCTTGGCCCGTGTTG GGAAGATGGGCCTGTTGGA 
NM_173925 IL8 Interleukin 8 TGCTTTTTTGTTTTCGGTTTTTG AACAGGCACTCGGGAATCCT 
NM_173923 IL6 Interleukin 6 AAACCGAAGCTCTCATTAAGCG TGGAAGCATCCGTCCTTTTC 
XM_001250668 CALM2 Calmodulin 2 
(predicted) 
CAAAGGAATTGGGAACTGTAATGA TCATGTCCTGTAACTCTGCTTCTGT 
BC_105484 NFKBIA NFKB inhibitor 
activator 
TCCTGCAGGCCACCAACTAC GCCATGAATAGAGGCCAAGTG 
NM_174348 ICAM1 Intercellular 
adhesion 
molecule 1 
TCTTGCCGCTGGGAACTG GGCCGAGGTGTTCTGGAA 
NM_198221 ITGAL Integrin alpha L GGAAGCCACCGACGAACA TCCCAATGATGTAGCGGATGA 
BC_114192 TGFB Transforming 
growth factor 
beta 
CGCAGAGCGGCCAAAG AAGACGAGCAATTTCATCACAAATAG 
NM_173893 B2M β2-
microglobulin 
ATGGAAAGCCAAATTACCTGAA GGGTTGTTCCAAAGTAACGTGT 
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Figure 27. Microarray-PCR comparison. Representative graphs comparing microarray and real-time PCR results for 
selected genes and tissues. One representative gene is shown for each tissue type assayed.
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DISCUSSION 
The mechanisms by which MmmSC evades or circumvents the host immune 
response are poorly understood, as are the details of how the host responds to infection.  
Most host response data for mycoplasmas focuses on the human or murine pathogens M. 
pneumoniae or M. arthriditis, which are phylogenetically distant from the mycoides 
cluster40.  It was a goal of this study to generate a global gene expression profile of cattle 
infected with MmmSC in an attempt to discover genes or pathways important in the 
molecular pathogenesis of infection.  
Involvement of the immune system is necessary for any host to overcome a 
pathogen.  Naïve hosts must first rely on the capabilities of the innate immune system, 
including granulocytes, monocytes/macrophages, natural killer cells, complement, and 
acute phase proteins.   The bronchoalveolar lavage samples obtained in this study should 
contain primarily macrophages, with variable numbers of neutrophils dependent on the 
state of infection110, although BAL cytology was not done during this study due to 
logistics issues.   
Investigation of the bovine host response to MmmSC infection had an early 
enhancement of the transcriptional profile followed by a gradual decline.  Inflammatory 
processes were strongly represented.  Microarray analysis of BAL samples revealed 
upregulation in a number of innate immune system genes in the first day following 
infection.  Macrophage-associated genes exhibiting early (Day 1) upregulation included 
CSF1, which stimulates differentiation of mononuclear phagocytes.  The 
proinflammatory neutrophil chemoattractant interleukin 8 (IL8) exhibited a dramatic 
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Day 1 increase (58-fold baseline) and the IL8 receptor was upregulated.  IL1A and IL1B 
were also significantly increased in expression.  The natural killer cell attractant IL12 
was moderately upregulated.  The gene CCR1, a macrophage stimulatory receptor, and 
its ligand CCL20 had strong early increases in transcription.  Monocyte chemotactic 
factors CCL2 and CCL8 also were upregulated early in infection, with CCL2 exhibiting 
a 34-fold increase over baseline levels on Day 1.  Multiple components of major 
histocompatibility class II (MHCII) complex molecules were increased in expression 
starting at Day 1 post-infection, potentially indicating immune system response to 
exogenous MmmSC antigen.  
The adhesion molecule ICAM1 was increased in expression on Day 1, as was L-
selectin (SELL).  A gene similar to CD209, Bt.9532, was upregulated.  CD209, which is 
expressed on dendritic cells, is a C-type lectin that stabilizes T cell receptor 
interaction111.  Lysosomal genes also demonstrated increases in expression, including 
LAMP1, the lysosomal cysteine protease CTSB, a cathepsin A-like transcript, and 
lysosomal α-mannosidase (MAN2B1).  A number of innate immune system genes 
normally associated with antiviral response were upregulated, including OAS1, MX2, 
and UBE1L. The antiviral gene Isg15, a ubiquitin homolog that is believed to influence 
dendritic cell migration112, was significantly increased in expression through Day 8, as 
was the putative interferon-induced transmembrane protein Bt.64826.  A transcript 
(Bt.33922) resembling the antiviral gene radical S-adenosyl methionine domain 
containing 2 (viperin) was also strongly upregulated on Days 1 and 8; viperin is known 
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to be induced by human cytomegalovirus infection, but is also induced by LPS and 
interferons113,114.   
There was also a large increase in expression of a gene resembling the eotaxin 
receptor (Bt.28967), which demonstrated a 46-fold increase over baseline levels on Day 
1 and remained at or above 10-fold above baseline throughout the experiment.  
However, eotaxin expression was not changed.  The gene NCR3, known to mediate 
dendritic cell/NK cell crosstalk as well as NK cell cytotoxicity115, was moderately 
upregulated.  The NK-cell and regulatory T cell-associated gene NKG7116-118 also 
demonstrated significantly increased expression throughout infection.  Natural killer 
cells are known to be activated by mycoplasma infection119,120, but their precise role in 
clearance of infection has not been determined.   
Other differentially-regulated genes associated with the innate immune system 
included complement factor 2 (C2), which was upregulated while C3 had moderate 
downregulation.  This could indicate preferential activation of the mannose-binding 
lectin complement pathway over the alternative pathway in early infection.  This may be 
supported by clinical evidence suggesting that mannose-binding lectin deficiency 
confers susceptibility to mycoplasma infections in humans121.  Slightly later in the 
experiment (Day 8), classical pathway complement components C1qa and C1qb were 
increased in expression, indicating that antibody-antigen complexes were likely present 
by this time.  Further supporting the presence of immune complexes was an upregulation 
of the gene Bt.28230, similar to complement component H, on Days 8 and 15.  
Component H traffics immune complexes from the site of formation to phagocytic cells 
  
90 
and limits the deposition of immune complexes in tissues122. The anticoagulant gene 
ANXA8 was downregulated while fibroleukin (FGL2) was upregulated, suggesting a 
procoagulant state.  FGL2 has also been suggested to downregulate T cell proliferation 
and dendritic cell maturation123.  In contrast to the procoagulant genes, the platelet 
adhesion factor CD36 was moderately downregulated. 
Additional innate immune components including the adhesion factor CD164, 
NOD2-like CARD15, the CCR5-binding ligand CCL3LI, and the antioxidant gene Sod2 
demonstrated moderately increased expression in early infection.  The gene Bt.643, 
whose product is similar to the neutrophil-secreted macrophage chemoattractant 
macrophage inflammatory protein (MIP), was strongly upregulated on Day 8 but not 
Day 1. This corresponds to the observed increase in pulmonary neutrophils over the 
course of CBPP. 
The bovine gene Bt.6915, which is similar to the human hemoglobin scavenger 
CD163, exhibited up to 30-fold baseline expression.  CD163 is produced in both 
membrane-bound and soluble forms by cells of the monocyte/macrophage lineage and 
the soluble form is shed in large amounts by activated macrophages124.  Soluble CD163 
is believed to be an anti-inflammatory mechanism, as scavenging of free hemoglobin 
decreases oxidative damage125.  Shedding of soluble CD163 by human monocytes may 
be induced by activation of Toll-like receptors TLR2, TLR4 and TLR5126-128.  
Interestingly, of these three Toll-like receptors only TLR4 had increased expression in 
BAL samples from the current experiment.  TLR4 recognizes the lipopolysaccharide 
(LPS)/lipopolysaccharide binding protein (LBP)/CD14 complex, which should only be 
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available in the presence of Gram-negative pathogens.  MmmSC, like all mycoplasmas, 
lacks a cell wall and does not elaborate LPS, although some mycoplasmas have been 
reported to activate the lipoprotein pattern recognition receptor TLR2129,130.   It is 
unclear from these data whether the increase in CD163 expression is due to TLR4 
activation by an unrecognized Gram-negative pathogen present in the experimental 
animals or due to TLR2 activation without increased TLR2 expression.  The 
Bt.6915/CD163-like transcript was strongly upregulated (16- to 42-fold) throughout the 
course of the experiment. 
The adaptive immune system is also involved in the response to MmmSC 
infection although, predictably, more so later in the course of disease.  Early indications 
of adaptive immunity are seen in the Day 1 expression of IL12B, which induces 
lymphocyte differentiation into the T-helper subset 1 (TH1) phenotype.  The CD80 gene, 
necessary for CD28 co-stimulation of T cells, also had increased expression between 
Days 1-15.  Several components of the T cell receptor complex CD3 were upregulated 
by Day 8, and a gene (Bt.26847) similar to linker for activation of T cells (LAT) was 
also moderately upregulated.  The LAT gene is expressed following activation of the T 
cell receptor (TCR) and recruits proteins into complexes near the site of the TCR.  
Several genes associated with heat shock proteins were upregulated on Day 8.  While 
heat shock proteins are considered part of the innate immune system, when complexed 
with antigen and presented to dendritic cells they are known to strongly activate TH1 
cells131-133.  Transcripts of the chaperonin Cct8, known to be upregulated by T cell 
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activation134, were also increased on Day 8.  Expression of Bt.28015, the provisional 
bovine Fcγ2 receptor, was also moderately increased through Day 15. 
The T cell pathways were not exclusively activated by MmmSC, but 
involvement of the humoral immune system in BAL samples appeared less prominent.  
The B cell growth-associated receptor CXCR4 (also known as stromal cell derived 
factor (SDF) 1α/β receptor) was upregulated, increasing in expression to Day 22, 
although SDF1 expression was only slightly above baseline.  The gene for the 
immunoglobulin j-chain remained unchanged until Day 22, when it increased 13-fold.  
The IL13 receptor subunit α-1 chain precursor expression was upregulated on Day 8, 
although IL13 was slightly downregulated at all time points.  IL13’s effects include B 
cell growth and differentiation, inhibition of the TH1 response and inhibition of 
macrophage inflammatory mediator production.  This expression pattern could suggest a 
need for continued activation of the TH1 response while maintaining maximal sensitivity 
for the humoral response.  Also appearing to diminish the contribution of the humoral 
immune system were decreases in transcription of the polymeric immunoglobulin 
receptor (pIgr), whose primary role is to transport secretory IgA through epithelial 
surfaces.  The overall appearance of the adaptive immune system during MmmSC 
infection appears to be one of primarily TH1 activation with a minimal TH2/B cell 
contribution.  However, the lack of transcripts from either TH1 or TH2 cell secreted 
products makes assessment tentative at best.  The lack of T lymphocyte transcripts may 
again be due to the predominantly macrophage/neutrophil cell type harvested by BAL.  
In normal animals there are 2 to 4.5% lymphocytes in BAL fluid110, but those 
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lymphocytes are reported to be mostly memory and CD8+ cells135,136.  These studies 
suggest that fewer than 0.4% of BAL cells in normal cattle are expected to be CD4+ T 
cells; this may be a partial explanation of the lack of detection of RNA transcripts in 
BAL fluid from either subpopulation of CD4+ cells.  No studies have specifically 
investigated alveolar lymphocyte subpopulations of cattle with bacterial respiratory 
disease, but an investigation of feedlot calves with naturally-occurring respiratory 
disease did not reveal differences in total lymphocyte percentage between affected and 
control calves137,138.  It would have been useful to directly assess soluble T helper subset 
cytokines in BAL fluid.   
The immune system is not entirely upregulated following infection with 
MmmSC.  Increased expression of SOCS3 at Day 1 indicates that there is some 
restriction of the proinflammatory cascade.  A degree of restraint is also indicated by the 
increased expression of TNFA1P6 (TSG6), which inhibits neutrophil migration and 
inflammation139,140.  The matrix metalloproteinase (MMP) inhibitor TIMP1 was 
increased in expression through Day 8, although MMPs were only slightly increased in 
expression in BAL fluid.  Matrix metalloproteinases degrade connective tissue matrix, 
and MMP2 and MMP9 have been identified in mycoplasmal disease141,142.  
Metalloproteinase inhibitors have been investigated as mediators of disease143; in a 
model of Johne’s disease, increased expression of TIMP1 was associated with 
persistence of the bacteria in cultured cells144, possibly suggesting a role for this gene in 
failure of disease clearance.  Vanin-1, a gene associated with granuloma formation and 
leukocyte transendothelial migration145-147, was downregulated in early infection, and 
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IL1R2, an inhibitor of IL1, was upregulated at Days 1 and 8.  The negative regulator of 
T cell activation Vsig4148 was also increased in expression through Day 8.  A gene 
similar to the mitogen-activated protein kinase (MAPK)-related nemo-like kinase was 
strongly upregulated in early infection.  Nemo-like kinase (NLK) inhibits beta-catenin 
lymphoid enhancer factor/T cell factor-mediated transcription149,150, and has also been 
implicated in suppression of nuclear factor kappa B (NFκB)-mediated transcription151.  
Nemo-like kinase is reported to be activated by STAT3 and IL6152, but neither were 
significantly differentially regulated in this sample type.  This suggests that an alternate 
activation mechanism for NLK may be present, or that this bovine NLK homologue may 
be activated via a different pathway than human or murine NLK. 
A number of other intriguing avenues are suggested by the data.  For example, 
the gene for connexin 43 is dramatically upregulated early in infection, reaching 148-
fold of baseline by Day 8.  Connexin 43, a component of the gap junction, has been 
implicated in the spread of Ca2+-mediated acute lung injury and is also known to be 
induced by LPS153,154.  The presence of increased expression by several LPS-responsive 
genes in BAL samples suggests either that TLR4 downstream pathways are being 
activated by other receptors (possibly TLR2 or TLR6) or the presence of an unidentified 
Gram-negative organism in the experimental animals.  Although two of the animals had 
evidence of resolved anteroventral pneumonia, characteristic Gram-negative organisms 
or active lesions were not identified at necropsy.   
The gene aquaporin 4 (Aqp4) was moderately downregulated throughout 
infection.  Aquaporins are integral membrane proteins that permit water transport along 
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osmotic gradients, and Aqp4 is known to be present in pulmonary epithelial cells.  
Aquaporins have been deemed unimportant in pulmonary water balance but have been 
implicated in the development of cerebral edema155,156, although little work has been 
done in models of lung injury157.  The decreased expression of Aqp4 in this experiment 
may potentially indicate one mechanism involved in the formation of the characteristic 
pulmonary interstitial edema seen in CBPP. 
Transcriptional responses were also frequently upregulated in early infection, as 
were antiapoptotic mechanisms.  Mail (NFKBIZ), an IL1-induced modulatory regulator 
of NFκB-mediated transcription158-160, was profoundly upregulated in early infection 
(104-fold).  Helix-loop-helix transcription factor BHLHB2 as well as both 
transcriptional mediators NFKB1 and NFKBIA were highly activated, and the NFκB 
activator and antiapoptotic gene osteopontin similarly had dramatic increases in 
expression.  Additional antiapoptosis genes having increased expression were 
GADD45B and BCL2A1. The pro-apoptotic gene Peg3 was downregulated throughout 
the experiment, but CASP4 was upregulated.  The overall trend was one of 
antiapoptosis, which was supported by the substantial increases in transcripts of multiple 
transcription factors and ribosomal proteins. 
The overall picture seen in bronchoalveolar lavage samples of MmmSC-infected 
cattle following infection is one of significant activation of the innate immune system, 
antiapoptosis, and large-scale transcriptional activation.  Multiple cytokine and 
chemokine production by macrophages recruit immune cells of both the innate and 
adaptive arms to the affected lung.  This activation continues at a lower level through 
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Day 8, and most innate immune system genes return to near-baseline levels by Day 15.  
Transcriptional activity also diminishes by Day 15, and most antiapoptosis genes trend 
toward baseline levels of transcription.  This gradual decrease in transcription mirrors 
the clinical picture in which infected animals that survived acute disease showed 
resolution of clinical signs. 
Results from this study are not in complete agreement with previous research on 
CBPP.  For example, TNFα was not significantly differentially regulated in 
bronchoalveolar lavage samples in this study, despite previous in vitro evidence 
demonstrating induction of macrophage TNFα production by virulent MmmSC64. 
However, TNF receptors were moderately upregulated in the current study.  Our 
experiment did demonstrate significant increases in expression of IL1A and IL1B, which 
are also produced by TNFα-producing macrophages, but did not find evidence of 
increased macrophage IL6 production in BAL samples.  The study mentioned above also 
demonstrated that pathogenic strains of MmmSC fail to induce procoagulant activity64, 
while the results from the current study demonstrate a procoagulant state following 
infection with MmmSC.  This disagreement may indicate a difference between in vitro 
versus in vivo results or strain differences between the mycoplasmas.  An ex vivo 
experiment generated evidence that IFNγ-producing CD4+ T cells were necessary for 
recovery from CBPP65.  The current investigation, again, did not provide evidence of 
differential regulation of IFNγ in bronchoalveolar lavage samples.  In addition, the 
current study revealed moderate downregulation of IL18, also known as interferon 
gamma inducing factor.  As the previous study evaluated IFNγ production using a 
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lymphoproliferation assay on peripheral blood mononuclear cells, reasons for the 
differing results could involve both variances between PMBC and alveolar macrophages 
and/or altered behavior of the cells outside the normal bovine environment.  Results may 
also differ because this aspect of the current study used pooled samples that did not take 
into account which animals survived and which did not.  A follow-on study to the one 
mentioned above suggested that live MmmSC could secrete a substance that induced 
apoptosis in both lymphocytes and granulocytes66. Although this substance has not been 
further defined, the study authors suggest that hydrogen peroxide should be considered 
for the role.  Our results demonstrate increased expression of two superoxide dismutase 
genes but no glutathione peroxidase genes, suggesting that hydrogen peroxide 
production was not prominent in BAL samples. 
In vivo studies of the immune response have demonstrated that cell-mediated 
immunity is important in the resolution of clinical signs65.  Additionally, MmmSC 
appears to be able to inhibit concanavalin A-induced blastogenesis and IFNγ production 
by PBMC and lymphocytes67, further intimating that cell-mediated immunity may be 
necessary for control of infection.  Our study failed to demonstrate mRNA in BAL 
associated with a cell-mediated response such as IFNγ, although gene expression 
products hinted at both a TH1 response and a humoral response. Contrary to the 
observations championing cell-mediated immunity is one study that demonstrated that 
passive immunity to CBPP could be transferred via serum68.  Investigations of the 
humoral immune response to MmmSC infection has documented a potent IgA response 
local to infection and a weaker systemic IgG response53, and that the response is stronger 
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in animals infected with more virulent strains of MmmSC. A different study suggested 
that increased IgA production was correlated with less severe disease, while other 
immunoglobulin isotypes were similar between animals with acute disease and those 
with subacute or chronic disease69. Multiple studies have suggested that the host 
response is in part responsible for the severity of lesions observed in CBPP, but the 
extent of this contribution is undetermined31,70,71.  Our investigations did not demonstrate 
increased expression of IgA or IgG, although several receptors for IgG were upregulated 
in early infection.  The Ig joining chain was prominently upregulated, however, which 
may be indirect evidence of increased IgA levels.  As was previously stated, the BAL 
cell population would not be expected to contain large numbers of B lymphocytes, 
which may explain the absence of detectable Ig transcripts.  This study was not able to 
directly sample lymphoid tissue during infection; such tissue would have been the 
desired sample for determination of immunoglobulin gene expression. 
Investigation of specific pathways involved in the bovine response to MmmSC 
infection may shed light on the mechanisms by which the host responds to infection.  
For example, the current study found a significant increase in the expression of 
interleukin 8 and interleukin 1B in bronchoalveolar lavage samples.  Interleukin 8 is a 
CXCL cytokine secreted by cells of the monocyte/macrophage lineage whose primary 
effect is that of polymorphonuclear leukocyte chemotaxis to mucosal surfaces.  IL8 is 
known to be induced by lipopolysaccharide; complement factor Xa, thrombin and fibrin 
can also activate endothelial cells, eliciting the synthesis of IL6 and/or IL8.  Little is 
known about the involvement of IL8 in mycoplasmal infections; a single in vitro study 
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of swine coinfection with M. hyopneumoniae and Porcine Respiratory and Reproductive 
Syndrome Virus identified increases in IL8 mRNA in pulmonary alveolar macrophages 
as well as soluble IL8 in culture supernatant, but this was true also for cells infected with 
either organism alone161.  A bovine in vitro study suggests that IL8 is a mediator of LPS-
induced endothelial injury in models of Mannheimia haemolytica infection162.  Given 
that mycoplasmas do not elaborate LPS, another component of MmmSC may be 
activating TLR4 normally activated by LPS or activating downstream pathways by other 
receptors.  It is known that diacylated lipopeptides present in some mycoplasmas are 
capable of binding to LPS-binding protein (LBP)163,164 and activating cells via TLR2130; 
it appears that MmmSC may be added to that list.  Some mycoplasmas, including M. 
arthritidis and M. fermentans, are known to elaborate superantigens such as macrophage 
activator lipoprotein-2 (MALP-2) that induce a shock-like syndrome identical to that 
induced by LPS165.  Neither MALP-2 nor any other superantigen has been identified as 
being produced by organisms in the mycoides cluster.  A study on the mechanisms of 
IL8 induction in human cells suggested that the extracellular signal-regulated kinase/ 
mitogen-activated protein kinase (ERK/MAPK) pathways were activated by 
mycoplasmal lysate166, although the specific mycoplasmal component was not identified.  
In the current study, the cytokine-cytokine receptor pathway, the MAPK signaling 
pathway and the Toll-like receptor signaling pathway were all ranked in the top 10 for 
bronchoalveolar lavage samples, supporting the importance of these pathway 
components in disease pathogenesis. 
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Bronchial biopsy samples.  The samples collected of bronchial tissue were 
expected to contain primarily ciliated bronchial epithelial cells.  The samples were taken 
with a 2.5mm endoscopic biopsy forcep and were found to be too small for standard 
histologic evaluation due to crush artifact; actual cell population could not be 
determined.  Innate immune system activation was dramatically different from that seen 
in bronchoalveolar tissue.  There was significant downregulation of most genes seen to 
be upregulated in BAL samples.  The exceptions included IL1A/B, which remained 
significantly upregulated, and granulocyte-monocyte colony stimulating factor (CSF2), 
which was moderately increased in expression.  Interleukin 6 (IL6) was significantly 
increased in transcription over baseline, which was not seen in BAL samples.  This 
suggests that the epithelial tissue macrophages respond differently than BAL 
macrophages to MmmSC. The monocyte chemoattractant CCL2 had increased 
transcription on Days 15 and 22, but not early in infection.  The T cell receptor CXCR3 
and ligand CCL5 (RANTES) both had increased expression, supporting the presence of 
both T cells and macrophages in biopsy samples. Adhesion factor CD164 was 
upregulated, as were antiviral-associated genes OAS3 and MAN2B1.  Coagulation 
cascade components Factor 9 and Factor 11 were upregulated, indicating a procoagulant 
state and activation of the intrinsic coagulation cascade.  This supports the report of 
MmmSC-induced procoagulant activity64, and may also reflect an MmmSC-potentiated 
response to tissue trauma caused by harvesting the biopsy.  Increased expression of 
complement component 5 suggests the construction of complement membrane attack 
complexes as well as increased chemotaxis of leukocytes by C5a.  The complement 
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component H-like gene Bt.28230 was upregulated throughout the experiment, likely 
indicating the formation of immune complexes within epithelial tissue.  Most heat shock 
proteins were decreased in transcription, but one (DNAJC3) was upregulated.   
The adaptive immune response in bronchial epithelial samples was again 
different from that in BAL fluid.  The IL2 receptor was moderately downregulated 
throughout the sampling period.  In addition, IL10 demonstrated moderate to large 
increases in transcription.  Interleukin 4 was not differentially expressed, but its receptor 
was upregulated.  These changes, plus the lack of increased expression of any TH1-
related transcripts, suggest that the bronchial epithelium is biased toward a TH2-like 
response.  However, we did not detect significant immunoglobulin heavy or light chain 
transcripts. Intriguingly, the immunoglobulin components Igj and pIgr were profoundly 
downregulated; this might be thought an unexpected finding given that secretory 
immunoglobulin should be present at epithelial surfaces.  An alternative hypothesis 
might be that infection with MmmSC downregulates IgA production, allowing increased 
microbial persistence.  Studies on M. pneumoniae167,168 and M. pulmonis169 have 
suggested that local immunity determines resistance to infection while systemic 
immunity is responsible for the pulmonary and systemic reactions, so downregulation of 
secreted IgA could be a useful means for MmmSC to establish a foothold in the lung.  
No studies have explored this possibility in mycoplasmas.  However, the lack of Ig-
related gene expression may be again explained by the possibility that we failed to 
capture epithelial lymphocytes and instead retrieved only non-Ig-secreting epithelial 
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cells.  Secreted antibody may have been present but we did not investigate its 
occurrence. 
One of the top-ranked pathways for differential gene expression in bronchial 
biopsy samples was the natural killer cell-mediated cytotoxicity pathway.  In comparison 
to BAL samples, this pathway was almost entirely downregulated, with 25 of 27 
evaluated transcripts demonstrating decreases in expression.  As a number of 
mycoplasmas have been demonstrated to activate NK cells119,120, the most likely 
explanation for the apparent inactivation of the NK cell pathway may again be the lack 
of effector cells in the harvested population.  Alternatively, MmmSC may induce 
downregulation of NK cells to permit its own proliferation.  No reports exist of this 
phenomenon in mycoplasmas.  Pathways related to cell metabolism, while still 
downregulated, were less so than many of the immune system pathways.  Once again, 
this is probably a reflection of the cell population acquired.  It would be interesting to 
develop a method of harvesting bronchus-associated lymphoid tissue (BALT) 
periodically during infection to observe the gene expression profiles therein, but the 
endoscopic sampling method used in this experiment did not allow such discrimination 
of tissues. 
Nasal cytology samples.  Nasal brushings were expected to contain primarily 
squamous epithelial cells due to the superficial nature of the acquisition method and the 
location swabbed (level of the medial canthus of the eye).  The construction of the 
sampling brush did not favor swabbing of pharyngeal lymphoid tissue, as the brush 
could not be angled after insertion into the nostril and the swabbing was done blindly.  In 
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nasal cytology tissue the gene expression profile was quite different from that found in 
the lower respiratory tract, either BAL or bronchial biopsy.  Most differentially-
regulated genes were not evident until Day 8.  Innate immune system involvement 
included evidence of NK cell activation via increased expression of NKG7, but the 
CXCR6 T cell/NK cell receptor was dramatically downregulated on Day 1 and 
moderately downregulated thereafter.  The CCL5 ligand was increased on Day 1, but its 
receptors were not.  The antiviral genes seen in BAL samples were not differentially 
regulated in nasal epithelial cells with the exception of UBE1L, which was highly 
expressed on Day 1 only.  IL8 transcripts were increased on Day 1 only.  CXCL6 
(GCP2) was strongly downregulated on Day 8, and other neutrophil markers were not 
differentially regulated.  This evidence suggests that neutrophils are not strongly 
recruited to nasal epithelium during MmmSC infection.  Such evidence supports the 
reports that nasal swabs are an inconsistent source of the mycoplasma81,170 and nasal 
epithelium is not a prominent site of infection.  These findings are further supported by 
nasal swabs collected during this experiment, in which mycoplasma was isolated from 
only approximately 40% of the samples (data not shown). 
Interleukin 1A in nasal epithelium was increased from Day 15 onward, while 
IL1B was increased only on Day 1.  IL6 was highly upregulated from Day 8 onward.  
None of the cytokines associated with a TH1 response (IFNγ, IL2, CSF2) were 
differentially regulated in nasal swab tissue.  TH2 cytokines IL3, IL5 and IL10 were also 
not differentially regulated, but IL4 had significant increases in expression starting on 
Day 8.  T cell receptor CD3 components were increased in expression, again 
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predominantly from Day 8 onward.  Complement components, with the exception of C5 
and the factor H-like transcript (Bt.28230) were decreased in expression.  This effect 
was most prominent on Day 1.  C5 was moderately upregulated and Bt.28230 was 
highly upregulated throughout infection.  Although the nasal epithelium is not a 
significant site of CBPP lesions, the intermittent MmmSC shedding by infected animals 
with the detection of Bt.28230 transcripts supports the implied presence of immune 
complexes in the tissue. Again, the Ig portion of the immune complex was apparently 
not produced by the cells that were sampled.  The Ig joining chain and polymeric Ig 
receptor transcripts were also highly downregulated in nasal epithelial swabs.  Minimal 
J-chain expression is expected since this component should be supplied by the Ig-
synthesizing B lymphocyte. Secretory component and pIgr are manufactured by 
secretory epithelial cells, but it is unknown whether we retrieved any of these cells 
during sampling. 
Blood samples. In blood samples the spectrum of expression again varied highly 
from other tissues, and was in several ways unexpected.  Most of the chemokines 
displaying differential expression in other samples did not do so in blood.  There was 
significant increase in expression of genes linked with antiviral response (OAS1, MX2, 
UBE1L, Isg15 and Bt.64826) on Days 1 and 8, and OAS1 remained upregulated through 
Day 22.  The viperin-like potentially antiviral transcript (Bt.33922) was also strongly 
upregulated on Day 1 and continued through Day 15; however, none of the inducing 
interferons appeared increased in expression.  Natural killer cell-associated genes 
displayed either no change or moderate downregulation.  ICAM1 was moderately 
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upregulated, but other adhesion molecules were not.  The antigen-presenting-cell-
associated CD86 was increased in expression through Day 15, but neither of its 
corresponding ligands was differentially expressed.  Neither complement components 
nor coagulation factors were differentially regulated.  The neutrophil-associated 
calgranulin S100A12 was strongly downregulated at all time points.  The gene Gprk5, 
which negatively regulates neutrophil chemotaxis171,172, was strongly downregulated on 
Days 1 and 8.  These data could suggest an increase of neutrophil transmigration into 
tissues.  The macrophage marker CD68 and the macrophage lysosomal phospholipase 
A2173 also had decreased expression in blood samples, possibly supporting a conclusion 
of macrophage migration into tissues.   
There was remarkably little change in expression for most cytokines, with a few 
exceptions. In contrast to all other tissue types evaluated, IL1A was moderately 
downregulated in early infection.  IL15 was downregulated at all time points.  
Interleukin 18 was strongly downregulated on Day 1 only.  Neither of the characteristic 
T helper cytokine subsets was differentially expressed.  IL15 and IL18 are both affiliated 
with the TH1 response, as IL15 promotes development of CD8+ memory cells and IL18 
is known to induce IFNγ.  The T cell receptor CD3 chains ε, γ and ζ all demonstrated 
decreases in transcription.  The B cell ligand CD80 was also moderately decreased in 
expression.  Immunoglobulin joining chain expression was increased through Day 15, 
but increases in immunoglobulin heavy or light chain transcripts were not detected.  The 
B cell-associated gene TNFRSF5 (CD40), which is involved with immunoglobulin class 
switching, memory cell development and formation of germinal centers, was 
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upregulated at all time points.   The gene TGFB1 was strongly increased at all time 
points.  TGFβ is known to inhibit both B and T cell proliferation, and is involved in the 
antibody class switch to IgA.  It is also implicated in the formation of regulatory or 
suppressor T cells174,175.  The overall lack of acquired immune system activation 
detected in blood samples might argue toward the presence of regulatory T cells, but 
their characteristic mRNA transcripts (CD25, Foxp3) are similarly absent.  Regulatory T 
cell involvement in mycoplasma infection has not been studied except with regard to the 
M. arthriditis superantigen, which has been found to exert an immunosuppressive effect 
through induction of a CD4+/CD8- T cell population176. The spectrum of gene expression 
present in blood, while not unequivocal, fits a pattern of primarily B cell activation and 
immunoglobulin production with indications of immune suppression.  This is partially in 
agreement with reports demonstrating a potent antibody response to infection with 
virulent MmmSC69,89,177,178. 
 The pattern of gene expression seen in the blood samples was unanticipated.  In a 
disease with a known septicemic component179,180 and in animals clearly demonstrating 
systemic clinical signs it might be expected to observe strong upregulation of most genes 
associated with the immune system.  This was clearly not the case, and a mechanism is 
not immediately apparent.  In retrospect it may have been beneficial to extract 
leukocytes from blood prior to isolation of RNA.  Although mature erythrocytes are 
anuclear, they maintain mRNA transcripts which may be isolated following 
phlebotomy181.  As erythrocytes significantly outnumber leukocytes but have a limited 
repertoire of transcripts, assay of mRNA from whole blood may have biased the data 
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collection to reflect predominantly erythrocyte transcripts.  Differential blood counts 
would also have contributed leukocyte population numbers, which might assist in 
interpreting the data. 
In summary, temporal evaluation of MmmSC-induced gene expression in four 
different cattle tissues revealed activation of many genes involved with innate immunity 
but was less revealing for genes of the acquired immune system.  A pattern of expression 
emerged indicating initiation of reaction to infection starting locally within the lower 
respiratory tract and later spreading to distant tissues.  Bronchoalveolar lavage and 
bronchial biopsy tissues demonstrated an activation of cells of the monocyte/ 
macrophage lineage within the first day post-infection, along with numerous innate 
immune system genes usually associated with antiviral response.  Signals expressed by 
BAL cells within the first day post-infection suggested recruitment of macrophages, 
neutrophils and natural killer cells out of the blood and into lung parenchyma, where 
their signals are obscured from our analysis after Day 8.  Increased expression of 
adhesins local to the lower respiratory tract but not in peripheral blood facilitates 
neutrophil and monocyte transmigration into the lung.  Solid evidence of TH1 versus TH2 
activation was lacking in the tissues sampled as was concrete evidence of B cell 
activation, but indirect evidence suggested an early tendency toward TH1 differentiation 
in the lower respiratory tract through Day 15 followed by a B cell response by Day 22.  
Complement and coagulation cascades were locally activated, and complement 
progressed from the mannose-binding pathway on Day 1 in BAL alone through classical 
pathway activation in both BAL and biopsy by Day 8 and evidence of membrane attack 
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complex formation in biopsy tissue by Day 15, indicating both a progression into deeper 
tissues and increased bactericidal activity coincident with disease resolution in surviving 
cattle. Lack of complement activation in nasal cytology samples upholds the lower 
respiratory predilection of MmmSC and further raises the possibility that lower 
respiratory tract complement activity may contribute toward the severe tissue damage 
seen in acute infection.  Additional evidence of host contribution toward disease-induced 
tissue damage in the first week of infection is provided by increased expression of 
lysosomal transcripts in the lower respiratory tract, coincident with neutrophil 
infiltration.  Proapoptotic transcripts were downregulated, and multiple transcription 
factors exhibited high expression.   
KEGG pathway activation further demonstrated the wide-ranging response to 
MmmSC infection, particularly in the lower respiratory tract.  The top-ranked BAL 
pathways were almost all associated with some aspect of the immune response.  
Bronchial biopsy pathways were similar to the BAL pathways and additionally displayed 
activation of pathways known to affect tissue damage such as oxidative phosphorylation, 
NK cell cytotoxicity and prostaglandin and leukotriene metabolism.  This interweaving 
of the functions of BAL and biopsy pathways demonstrates the profound effects 
MmmSC infection has on the lower respiratory tract and provides additional candidate 
genes for host-induced self-tissue damage during MmmSC infection.  Pathways 
activated in nasal cytology samples, while still part of the immune response, were not as 
proinflammatory as lower respiratory tract pathways.  These pathways, present in a 
tissue with little inflammation, suggest that other pathways should be explored first 
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when seeking host genes exploited by MmmSC to cause tissue damage.  Blood pathways 
remain cryptic; while some are clearly affiliated with endothelial cell metabolism, the 
association of others with the response to infection is undetermined.  While many of the 
top-ranked pathways in each tissue were affiliated with the immune or inflammatory 
response, a number of pathways apparently unrelated to immune response also showed 
strong differential expression.  These included several involving hormone and amino 
acid metabolism, lipid metabolism, insulin and diabetes, and ethylbenzene degradation; 
further work will be needed to determine their contribution to disease pathogenesis. 
Most differentially-expressed host genes during MmmSC infection had strong 
alterations in expression on the first sampling day post-infection followed by a gradual 
return toward baseline expression.  Additionally, the spectrum of gene activation was 
quite different in each tissue although functions often complemented each other, 
especially between BAL and biopsy samples.  Future studies might augment this 
information with targeted collection of lymphoid tissues and/or simultaneous evaluation 
of secreted gene products to better determine the involvement of lymphocytes.  
Application of other techniques such as laser capture microdissection or proteome 
analysis may also assist in better elucidating the nature of the host response to infection.  
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CHAPTER IV 
 
COMPARATIVE STRAIN AND SURVIVOR ANALYSIS IN CATTLE 
INFECTED WITH MYCOPLASMA MYCOIDES MYCOIDES SMALL COLONY 
 
INTRODUCTION 
 Mycoplasma mycoides mycoides small colony (MmmSC) has been found to 
affect the expression of a multitude of genes in the bovine host, but the mechanism by 
which each gene influences the outcome of infection is unknown.  Global gene 
expression was investigated using microarrays to detect mRNA transcripts, but this 
method is only semiquantitative.  Microarray results must be confirmed with a more 
sensitive method such as real-time polymerase chain reaction (RT-PCR).  The purpose 
of this segment of the experiment was to directly compare gene expression of selected 
genes across all tissues and time points using RT-PCR following infection with one of 
three strains of MmmSC.  The second objective was to compare selected genes between 
Gladysdale-infected survivors and nonsurvivors to determine if any of the selected genes 
appeared to influence host survival. 
 
MATERIALS AND METHODS 
 For this portion of the experiment, the animals, inoculum, and clinical samples 
collected were the same as those presented in Chapter II, using MmmSC strains 
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Gladysdale, Ondangwa and Shawawa.  RNA was extracted from clinical samples using 
the protocol described in Chapter III. 
Reverse transcription of RNA.  For the strain comparison, pooled samples were 
used.  Each individual animal contributed 0.4 µg of purified RNA to create a pooled 
aliquot of 2 µg RNA.  The aliquots were reverse transcribed into cDNA using TaqMan 
(Applied Biosystems).  For relative quantitation of target cDNA, samples were run in 
duplicate in individual tubes in a SmartCycler I (Cepheid). One SmartMix bead 
(Cepheid) was used for 2 x 25 l PCR reactions along with 20 ng of cDNA, 0.2X SYBR 
Green I dye (Invitrogen) and 0.3 M forward and reverse primers (Sigma Genosys) 
designed by Primer Express Software v2.0 (Applied Biosystems) or Primer3Plus 
(www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) (Table 8). Not all genes in 
Table 8 were evaluated in each comparison.  For each gene tested, the individual 
calculated threshold cycles (Ct) were averaged among each condition and normalized to 
the Ct of the bovine β2-microglobulin gene from the same cDNA samples before 
calculating the fold change using the Ct method (Applied Biosystems Prism SDS 
7700 User Bulletin #2). Due to the nature of this calculation in which all results were 
averaged prior to determination of Ct, no error bars could be generated.  For each 
primer pair, a negative control (water) and an RNA sample without reverse transcriptase 
(to determine genomic DNA contamination) were included as controls during cDNA 
quantitation. 
 For the survivor-nonsurvivor comparison, only strain Gladysdale was used.  
Animals were divided into two groups: nonsurvivors included the two animals 
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euthanized early in the experiment, while survivors included the other three animals that 
resolved infection and were euthanized on Day 36.  Individual animal cDNA was 
transcribed using TaqMan as described above, then group aliquots were created by 
combining equal amounts of individual animal cDNA.   Comparisons were conducted 
only for Days 1 and 8, as nonsurvivors were euthanized prior to Day 15.   
 
RESULTS 
Nine genes were compared between strains Gladysdale, Ondangwa and 
Shawawa.  Gene expression was compared in bronchoalveolar lavage fluid, bronchial 
biopsy, and nasal cytology brushings.  Blood was not compared as insufficient RNA was 
obtained from Ondangwa and Shawawa-infected animals’ blood samples.  The genes 
compared included interleukin 6 (IL6), nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor, alpha (NFKBIA), interleukin 18 (IL18), calmodulin 2 
(CALM2), ferritin heavy polypeptide 1 (FTH1), interleukin 8 (IL8), mitogen activated 
protein kinase 1 (MAPK1), interleukin 1B (IL1B), and signal transducer and activator of 
transcription 3 (STAT3).  Genes were selected based on early Bayesian modeling of 
microarray data suggesting that each gene might be involved in disease pathogenesis in 
at least one tissue type. 
Bronchoalveolar lavage strain comparison.  Real-time PCR results of BAL 
samples showed no major differences between the three strains for genes IL6 or CALM2 
(Figure 28).  The Shawawa strain demonstrated much less induction of NFKBIA in  
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Figure 28. RT-PCR fold changes for bronchoalveolar lavage.  A. gene interleukin 6 
(IL6); B. gene nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor, alpha (NFKBIA); C. gene interleukin 18 (IL18); D. gene calmodulin 2 
(CALM2); E. gene ferritin heavy polypeptide 1 (FTH1); F. gene interleukin 8 (IL8); G. 
gene mitogen activated protein kinase 1 (MAPK1); H. gene interleukin 1B (IL1B); I. 
gene signal transducer and activator of transcription 3 (STAT3). 
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infected cattle than Gladysdale or Ondangwa.  Infection with either Ondangwa or 
Shawawa induced greater transcription of IL18 than infection with Gladysdale, 
particularly from Days 1-15.  For FTH1, Ondangwa-infected cattle showed the highest 
levels of transcription, with Shawawa-infected animals exhibiting very low levels.  
Interleukin 8 expression was dramatically increased for both Gladysdale and Ondangwa-
infected animals, but peak expression differed temporally between the strains.  Shawawa 
also demonstrated increased IL8 expression, but not to the extent of the other strains.  
Expression of MAPK1 was highest in animals infected with strain Ondangwa, but the 
differences were not large.  Gladysdale-infected animals showed the greatest expression 
of IL1B, but all strains induced increases in expression.  Both Ondangwa and Shawawa-
infected animals demonstrated greater transcription of STAT3 than Gladysdale-infected 
animals starting on Day 8. 
Bronchial biopsy strain comparison.  Interleukin 6 induction was greater in 
Gladysdale-infected animals (Figure 29).  All animals showed decreases in NFKBIA 
expression, but Shawawa-infected cattle demonstrated dramatic downregulation in early 
infection.  Interleukin 18 expression was increased in Ondangwa-infected animals but 
decreased below baseline levels in animals infected with the other strains.  All infected 
animals showed downregulation of CALM2, with Ondangwa-infected cattle showing the 
greatest decrease in expression.  All infected animals showed increases in IL8 expression 
on Day 1, but only Ondangwa-infected animals continued to demonstrate increased 
expression through Day 8.  MAPK1 expression was increased in all groups, but  
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Figure 29. RT-PCR fold changes for bronchial epithelial cells.  A. gene interleukin 6 
(IL6); B. gene nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor, alpha (NFKBIA); C. gene interleukin 18 (IL18); D. gene calmodulin 2 
(CALM2); E. gene ferritin heavy polypeptide 1 (FTH1); F. gene interleukin 8 (IL8); G. 
gene mitogen activated protein kinase 1 (MAPK1); H. gene interleukin 1B (IL1B); I. 
gene signal transducer and activator of transcription 3 (STAT3). 
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Ondangwa-infected cattle showed higher expression from Days 1-8.  For IL1B, 
expression in Ondangwa- and Shawawa-infected animals was only slightly increased, 
but Gladysdale-infected animals showed a sustained increase peaking on Day 22.  
STAT3 expression was downregulated from Days 1-8 but upregulated from Days 15-29 
in Gladysdale-infected animals.  Ondangwa-infected animals showed downregulation 
only on Day 1, and Shawawa-infected animals showed virtually no change from 
baseline. 
Nasal cytology strain comparison.  Interleukin 6 expression in Gladysdale-
infected animals was greatly increased over the other strains (Figure 30).  Ondangwa-
infected animals showed moderate increases over baseline, while Shawawa-infected 
animals showed almost no change.  No differences were noted in NFKBIA expression 
between strains.  Only Shawawa-infected animals demonstrated changes in expression in 
IL18; a moderate increase was noted early in infection.  Shawawa-infected cattle also 
showed a Day 1 increase in CALM2 expression while animals infected with other strains 
did not.  FTH1 expression did not differ between strains and was never far from 
baseline.  All strains induced increases in IL8 expression in the host animal on Day 1, 
but only Shawawa-infected animals continued the increased expression through Day 8.  
MAPK1 expression did not vary greatly from baseline, and no difference was seen 
between strains.  All strains induced an early increase in IL1B expression, but only 
Gladysdale induced IL1B downregulation later in infection.  No strain differences were 
noted in STAT3 expression, which never altered greatly from baseline. 
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Figure 30. RT-PCR fold changes for nasal epithelial cells.  A. gene interleukin 6 
(IL6); B. gene nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor, alpha (NFKBIA); C. gene interleukin 18 (IL18); D. gene calmodulin 2 
(CALM2); E. gene ferritin heavy polypeptide 1 (FTH1); F. gene interleukin 8 (IL8); G. 
gene mitogen activated protein kinase 1 (MAPK1); H. gene interleukin 1B (IL1B); I. 
gene signal transducer and activator of transcription 3 (STAT3). 
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        Survivor-nonsurvivor comparisons. Gene expression in the three Gladysdale-
infected animals that survived until Day 36 was compared to gene expression in the two 
animals that were euthanized on Days 10 and 13 due to severe disease.  Six genes were  
compared: interleukin 6 (IL6), nuclear factor of kappa light polypeptide gene enhancer 
in B-cells inhibitor, alpha (NFKBIA), interleukin 18 (IL18), calmodulin 2 (CALM2), 
ferritin heavy polypeptide 1 (FTH1), and interleukin 8 (IL8). 
Bronchoalveolar lavage survivor comparison.   Nonsurviving animals showed 
IL6 expression that was one-third greater than surviving animals on Day 1, but was 
threefold that of surviving animals on Day 8 (Figure 31).  Similarly, expression of 
NFKBIA in bronchoalveolar lavage of nonsurvivors was threefold that of survivors on 
Day 1 and twice that of survivors on Day 8.  Expression of interleukin 18 on Day 1in 
nonsurvivors was less than half that of survivors, but this difference had diminished by 
Day 8.  Expression of CALM2 was not greatly different between groups on Day 1, but 
on Day 8 nonsurvivors demonstrated a fivefold decrease in expression when compared 
to survivors.  No difference between groups was seen in expression of FTH1.  While all 
animals demonstrated profound induction of IL8 expression, less than twofold difference 
was seen between surviving and nonsurviving cattle. 
Bronchial biopsy survivor comparison.  Both groups showed large increases in 
IL6 gene expression on Day 8, but there was no difference between the groups (Figure 
32).  Similarly, there was no discernable difference in NFKBIA expression, IL18 
expression, CALM2 expression or FTH1 expression.  Interleukin 8 evaluation did show  
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Figure 31. Survivor vs. nonsurvivor gene expression in bronchoalveolar lavage. A. 
gene interleukin 6 (IL6); B. gene nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor, alpha (NFKBIA); C. gene interleukin 18 (IL18); D. gene 
calmodulin 2 (CALM2); E. gene ferritin heavy polypeptide 1 (FTH1); F. gene 
interleukin 8 (IL8). 
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Figure 32. Survivor vs. nonsurvivor gene expression in bronchial epithelial cells. A. 
gene interleukin 6 (IL6); B. gene nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor, alpha (NFKBIA); C. gene interleukin 18 (IL18); D. gene 
calmodulin 2 (CALM2); E. gene ferritin heavy polypeptide 1 (FTH1); F. gene 
interleukin 8 (IL8). 
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Figure 33. Survivor vs. nonsurvivor gene expression in nasal epithelial cells. A. gene 
interleukin 6 (IL6); B. gene nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor, alpha (NFKBIA); C. gene interleukin 18 (IL18); D. gene calmodulin 2 
(CALM2); E. gene ferritin heavy polypeptide 1 (FTH1); F. gene interleukin 8 (IL8). 
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Figure 34. Survivor vs. nonsurvivor gene expression in blood. A. gene interleukin 6 
(IL6); B. gene nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor, alpha (NFKBIA); C. gene interleukin 18 (IL18); D. gene calmodulin 2 
(CALM2); E. gene ferritin heavy polypeptide 1 (FTH1); F. gene interleukin 8 (IL8). 
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a threefold greater expression in surviving animals over nonsurvivors on Day 1, but this 
difference had vanished by Day 8.   
Nasal cytology survivor comparison.  Evaluation of IL6 expression 
demonstrated a profound difference between survivors and nonsurvivors in which 
survivors showed a more than twentyfold increase in expression on Day 1 and more than 
tenfold on Day 8 (Figure 33).  Similarly, a fivefold greater NFKBIA expression was 
seen in survivors on Day 1, although that difference had disappeared by Day 8.  No large 
differences were noted in expression of IL18 or CALM2 between groups.  For FTH1, 
survivors demonstrated a fourfold increase in expression over nonsurvivors on both Day 
1 and Day 8.  Expression of IL8 was more than twentyfold greater in survivors on Day 1, 
but no difference remained on Day 8. 
Blood survivor comparison.  Interleukin 6 expression was more than sixfold 
greater in nonsurvivors on both Day 1 and Day 8 (Figure 34).  No major differences 
were noted between groups for NFKBIA, IL18, CALM2, FTH1 or IL8 expression.   
 
DISCUSSION 
 Differences in disease severity, morbidity and mortality between strains of 
MmmSC are well-recognized.  The most prominent factor influencing differential 
severity based on published literature would appear to be assignation of a given 
MmmSC strain into one of the two major clusters, African/Australian or European182.  
African/Australian isolates are reported to demonstrate significantly higher morbidity 
and mortality over European isolates183.  There is an 8.8-kb deletion in the European 
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cluster, and several investigations have been conducted in that region in search of 
virulence factors differentiating the African/ Australian and European strains.  
Sequencing of the deletion area present in the African strains has been conducted and 
has identified five open reading frames including the membrane lipoprotein LppB and 
the glycerol transport cassette components gtsB and gtsC43-46,184,185.   
 Studies comparing the host response to infection with different strains of 
MmmSC have previously focused on detection of secreted products or mitogen 
activation53,64,65,69,97.  No studies have been published evaluating host gene expression 
for any organism in the mycoides cluster.  The current study used real-time polymerase 
chain reaction to investigate the expression of selected genes in the bovine host after 
infection with one of three African/Australian strains of MmmSC.  The clinical results 
seen in this study demonstrated Gladysdale as the most virulent isolate, followed by 
Ondangwa, and Shawawa as the least virulent of the three strains. 
 Interleukin 6 is a multifunctional pyrogenic cytokine secreted by activated 
macrophages.  It is known to stimulate innate immunity by inducing synthesis of hepatic 
acute-phase proteins, increasing vascular permeability and coagulation and activating 
both T and B cells.   Its induction in cases of human mycoplasmal pneumonia has been 
described186, but an experiment involving M. hyopneumoniae failed to find increased 
soluble IL6 in culture supernatant161.  A murine study linked pulmonary IL6 expression 
with mortality in polymicrobial sepsis187 and suggested that IL6 and its transcription 
factors could play a role in the initiation and propagation of acute lung injury.  The small 
increase in IL6 gene expression seen in BAL fluid with all three strains of MmmSC 
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suggests that this cytokine is not a significant mediator of differential disease severity, 
since the predominantly macrophage population of BAL fluid should be a significant 
source of IL6.  However, the prominent increase in IL6 mRNA transcription over 
baseline levels in bronchial biopsy and nasal cytology samples from Gladysdale-infected 
animals argues for a role for this cytokine.  IL6 in these samples would be expected to 
result from the inclusion of tissue macrophages within the bronchial or nasal epithelium.  
Since activation of macrophages is usually accomplished via phagocytosis of particulate 
antigen (the mycoplasma), it is difficult to comprehend a scenario in which embedded 
tissue macrophages would encounter the mycoplasma before the alveolar macrophages.  
One possible explanation might be that alveolar macrophages may already be in an 
activated state, so there is no apparent increase in cytokine secretion over baseline.  
Potential inciting stimuli for alveolar exposure to particulate antigen and activation of 
alveolar macrophages in this experiment include confinement housing and the 
endoscopic lavage procedure.  Epithelial macrophages might be more protected from 
ready access to environmental antigens and could have a lower baseline expression of 
cytokines, making the differential expression upon exposure more prominent.  
Regardless of the method of macrophage activation, the differential expression of this 
cytokine by Gladysdale-infected cattle does suggest its involvement in disease severity. 
 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, 
alpha (NFKBIA) is an inhibitor of the transcription factor complex NFKB.  Activated 
NFKB complex translocates into the nucleus and binds DNA at kappa B binding motifs. 
NFKBIA, an I kappa B protein, inactivates NFKB by trapping it in the cell cytoplasm. 
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Phosphorylation of serine residues on the I kappa B proteins by kinases marks them for 
destruction via the ubiquitination pathway, allowing reactivation of the NFKB complex.  
NFKB is involved in the transcription of many cytokines, and has been implicated in the 
pathogenesis of diseases in several species.  Mycoplasmal lipoproteins have been shown 
to activate NFKB via TLR signaling188-190.  Increased expression of NFKBIA has been 
described in human sepsis191, but not in any mycoplasmal diseases.  Induction of 
NFKBIA and inhibition of the cytokine-transcribing NFKB might be expected to 
increase the severity of disease by hamstringing the host immune response.  
Alternatively, inhibition of host proinflammatory cytokines may ameliorate tissue 
damage caused by overwhelming immune system activation.  Strain Gladysdale, the 
most pathogenic of the three strains, had the largest increase in NFKBIA expression in 
BAL fluid.  Ondangwa also had large increases in expression, but Shawawa did not.  
This correlates with the relative pathogenicity of each MmmSC strain.  However, this 
was not the case in bronchial biopsy or nasal cytology samples, in which NFKBIA 
expression was inconsistent and variable.  The BAL results suggest that NFKBIA may 
inhibit transcription of genes involved in disease pathogenesis, but determining the 
identity of these genes will require further investigation. 
 Interleukin 18 is best known as an inducer of proliferation of and IFNγ 
production by TH1 cells and NK cells.  It also promotes differentiation of T cells into the 
TH1 phenotype.  Mycoplasmal infections have been shown to induce IL18 production 
without IFNγ production in both humans and swine192-195.  MmmSC has been 
demonstrated to depress IFNγ secretion,67 although assessment of IL18 was not 
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conducted in that experiment.  IFNγ production has been linked to survival in animal 
models of mycoplasmal infection including CBPP65,97.  The presence of increased 
amounts of IL18 mRNA in Ondangwa- and Shawawa-infected cattle BAL and bronchial 
biopsy samples and the lesser amounts of IL18 in Gladysdale-infected samples might 
argue toward support of the IFNγ-dependent recovery hypothesis, with more pathogenic 
strains of MmmSC depressing the IL18 and IFNγ responses.  This would not take into 
account the potential for IL18 expression without IFNγ production as has been 
described. This possibility should be considered in MmmSC infection, since our 
microarray data fail to show increased expression of IFNγ in the face of IL18 expression 
in Gladysdale-infected animals.   
 Calmodulin 2 is one of a family of calcium-binding proteins of which nearly 20 
members have been found. Calmodulins are cytosolic proteins that bind to other proteins 
as activators.  Their functions include roles in growth and the cell cycle as well as signal 
transduction and neurotransmitter synthesis and release. Calmodulin has been minimally 
investigated in the context of mycoplasmal infections, with most evidence suggesting 
that infection with mycoplasma induces release of calmodulin from the affected 
cell196,197.  Investigation of intracellular calmodulin in a swine mycoplasma model failed 
to find any difference between infected and control tissues198, so the increased 
extracellular calmodulin found in the other studies may reflect only cellular damage 
rather than actual change in calmodulin production.  There was no discernable difference 
in CALM2 expression between our three strains when examining BAL or nasal cytology 
samples.  In bronchial biopsy samples, strain Ondangwa demonstrated a moderate but 
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persistent downregulation, but the significance of this in disease pathogenesis is 
unknown.   
 Ferritin heavy polypeptide 1 (FTH1) encodes the heavy subunit of ferritin, the 
major intracellular iron storage protein in prokaryotes and eukaryotes. The best-
characterized role of ferritin is cellular storage of iron in a soluble and nontoxic state. 
Sequestration of iron is a well-recognized host innate immune system strategy during 
microbial infection, although it is usually considered most significant during infection 
with intracellular organisms.  Lactoferrin is considered to have the primary role in iron 
sequestration, but there is evidence that ferritin may also play a role199,200.  No 
investigations have been done toward the role of host iron sequestration in resolution of 
mycoplasmal infection.  One array-based bacteriologic study demonstrated 
transcriptional changes in mycoplasma grown under iron-restricted conditions201, 
indicating that mycoplasma may be susceptible to iron sequestration strategies by the 
host animal.  Comparison of our three MmmSC strains showed little correlation of FTH1 
expression with disease pathogenicity.  The only consistent alteration in expression was 
moderate upregulation of FTH1 in Ondangwa-infected BAL samples.  Whether the 
increase in FTH1 expression in animals infected with strain Ondangwa has any bearing 
on the severity of lesions or disease resolution is unknown. 
 The cytokine interleukin 8 is a macrophage-secreted CXC chemokine best 
known as a neutrophil chemoattractant, but it has secondary roles in T cell and basophil 
chemotaxis.  The single study investigating IL8 in mycoplasmal infection identified 
increased levels of the cytokine in swine tracheal explants161, but did not propose a 
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mechanism.  An experiment using a mycoplasmal lipid-associated membrane protein 
also stimulated production of IL8 by human monocytes and identified the mitogen active 
protein kinase (MAPK) cascade as a downstream pathway202.  Our data would indicate a 
potent role for IL8 in host response to CBPP, as all strains demonstrated dramatic 
increases in IL8 gene expression in BAL fluid.  Both Gladysdale and Ondangwa 
exhibited over 100-fold increases in IL8 expression over baseline but showed differential 
timing of maximal expression.  However, given that all strains showed upregulation, this 
cytokine seems unlikely to be a primary determinant of differential pathogenicity 
between strains based on BAL samples.  Bronchial biopsy samples showing increased 
IL8 expression of Gladysdale-infected animals over Ondangwa- or Shawawa-infected 
animals may imply greater neutrophil-induced oxidative damage in bronchial 
epithelium.   
 Mitogen activated protein kinase 1 (MAPK1), also known as extracellular signal-
regulated kinase (ERK), is involved in a number of cellular processes including 
differentiation, proliferation and transcriptional regulation. Activation of MAPK1 
requires its phosphorylation by upstream kinases. Following activation, MAPK1 
translocates to the nucleus of the cell and phosphorylates nuclear targets. As mentioned 
in the previous paragraph, MAPK1 is part of a signaling cascade resulting in the 
transcription of cytokines including IL8.  A previous study by the same group identified 
MAPK1/ERK as necessary in the signal transduction for transcription of IL1B and 
TNFα, but not IL6, following exposure to mycoplasmal lipoproteins203.  Among the 
three MmmSC strains evaluated in our study, the Gladysdale isolate showed the lowest 
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MAPK1 expression but the highest IL8 and IL1B expression in BAL samples.  Animals 
infected with strains Ondangwa and Shawawa showed greater BAL transcription of 
MAPK1 yet lower expression of the proinflammatory cytokines whose transcription is 
controlled by MAPK1.  This suggests the involvement of other downstream regulatory 
mechanisms that may interrupt the signal transduction cascade prior to transcription.  
Candidates for this include the kinases that influence the phosphorylation state of 
MAPK1 such as DUSP14 or PTPN7.    Biopsy samples showed higher expression of 
MAPK1 in Ondangwa-infected animals and nasal cytology samples did not demonstrate 
a consistent expression pattern.  The host MAPK1 response to infection with certain 
other bacteria is believed to be calmodulin-dependent;204,205 but our data do not appear to 
link calmodulin expression with MAPK1 expression. 
 Interleukin 1B is another macrophage-secreted cytokine whose roles include 
pyrogenesis, stimulation of acute-phase protein synthesis, increasing expression of 
adhesion molecules, platelet and fibroblast proliferation, T and B cell activation and 
induction of additional proinflammatory cytokines including IL6 and IL8.  IL1B is a 
downstream product of the MAPK/ERK signaling cascade.  IL1B expression has been 
shown to be dependent on calmodulin in an LPS-induced model206, but the calmodulin-
dependent IL1B pathway has not been confirmed for mycoplasmas.  Multiple 
mycoplasmas have been shown to induce IL1B production, including M. bovis, M. 
synoviae, M. pneumoniae, M. hyopneumoniae and M. pulmonis207-211.  MmmSC’s ability 
to induce IL1B production has not been evaluated, and only one study has investigated 
IL1B secretion in any mycoides cluster organism212. Our study demonstrates the 
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induction of IL1B gene expression in BAL fluid of at least fourfold over baseline by all 
three strains of MmmSC in infected cattle.  The magnitude of strain differences in BAL 
IL1B expression reflected the relative severity of disease induced by each strain, with 
Gladysdale>Ondangwa>Shawawa.  Slight increases in expression were seen in bronchial 
biopsy samples but only reached fourfold over baseline in animals infected with strain 
Gladysdale.  Gladysdale animals also showed a brief spike in IL1B expression in nasal 
cytology samples on Day 1 only.  Our data suggest that IL1B likely has a role in the 
pathogenesis of CBPP. 
 The protein encoded by the gene signal transducer and activator of transcription 
3 (STAT3) is a member of a group of proteins that is phosphorylated by receptor-
associated kinases in response to cytokines and growth factors.  Following 
phosphorylation, STAT proteins form homo- or heterodimers that function as 
transcriptional activators after translocation to the cell nucleus213. Some of the cytokines 
and growth factors known to induce phosphorylation of STAT3 are interferons, 
epidermal growth factor, IL5, IL6, hepatocyte growth factor, leukemia inhibitory factor 
and bone morphogenetic protein 2214.  This protein mediates gene expression for a 
number of genes, depending on the specific stimulus, and thus plays a key role in many 
cellular processes including apoptosis and cell cycle. While no studies have investigated 
the role of STAT3 in mycoplasmal infection, investigations involving other bacteria 
have assigned STAT3 roles including that of a mediator of T cell activation215 and 
neutrophil recruitment216.  One model using Salmonella porins demonstrated a 
dependence of STAT3 on the MAPK pathway instead of its well-known dependence on 
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Janus kinase (JAK) phosphorylation for activation217.  In our experiment, animals 
infected with strain Ondangwa demonstrated a consistent increase in STAT expression 
in BAL fluid while Shawawa-infected animals showed a single high peak on Day 8.  
Bronchoalveolar lavage STAT3 expression in Ondangwa-infected animals roughly 
paralleled MAPK1 expression, but did not do so in other sample types.  No parallels 
could be seen between STAT3 expression and IL6 expression in any sample type.  
Investigation of the STAT pathway may identify dependent genes in mycoplasmal 
infection. 
 Comparison of surviving and nonsurviving animals infected with strain 
Gladysdale identified some intriguing avenues for exploration. While bronchoalveolar 
lavage expression of IL6 did not differentiate between survivors and nonsurvivors, 
evaluation of IL6 mRNA in blood samples demonstrated increased expression in 
nonsurviving cattle.  The same comparison in nasal brushings showed the opposite 
pattern, with surviving cattle exhibiting greater expression of IL6. This is somewhat in 
conflict with the murine study mentioned previously, in which IL6 was proposed as a 
mediator of lung injury187; that investigation would imply that nonsurvivors should have 
greater expression of IL6 in the lung.  That study, however, evaluated pulmonary IL6 
transcription factors rather than BAL fluid cytokine, and expression may well differ 
between lung tissue and pulmonary macrophages.  In addition, quantity of a transcription 
factor does not necessarily correlate with quantity of its cytokine.   
Evaluation of NFKBIA showed that nonsurvivors more than doubled expression 
in BAL fluid while survivors had a fourfold increase in nasal epithelial cells.  The 
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situation in BAL fluid correlates with hypotheses of NFKBIA’s role in the pathogenesis 
of other infectious disease191.  NFKBIA inhibits NFKB-mediated cytokine transcription, 
and absence of specific cytokines may negatively influence disease outcome.  If 
NFKBIA is inhibiting cytokine expression in our model it would appear not to be doing 
so for either IL6 or IL8, which showed increased expression in both groups of animals.  
Interleukin 18, however, does show decreased expression in BAL fluid of nonsurvivors; 
perhaps it might be proposed as a candidate for NFKBIA-mediated downregulation.  
Bronchoalveolar lavage IL18 expression in nonsurvivors versus survivors was in 
agreement with other reports suggesting that IL18 production and subsequent IFNγ 
secretion enhance survival in mycoplasmal infections65,194.  No other sample types 
exhibited this pattern. 
Calmodulin 2 showed greater downregulation in nonsurvivors than survivors in 
BAL fluid, while alterations of expression in other sample types were not sufficiently 
large to draw conclusions.  Calmodulin’s role as a transcriptional activator implies that 
decreases in CALM2 expression may have far-reaching consequences on downstream 
activation of other genes.  However, the apparent decrease in calmodulin expression in 
our nonsurvivor group does not appear to have affected IL8 expression, a relationship 
found in cells treated with Mycobacterium products204 and Clostridium toxins218.  The 
role of CALM2 in MmmSC infection cannot be hypothesized from this data. 
Ferritin heavy chain 1 showed differential expression only in nasal brushing 
samples, in which survivors had a three- to fivefold increase in expression over 
nonsurvivors.  This could reflect successful sequestration of iron by host cells leading to 
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elimination of the mycoplasma, but if that were the case the difference should also be 
observable in BAL or bronchial biopsy samples closer to the site of maximum 
mycoplasma presence.  Further investigation is needed to elucidate the involvement of 
FTH1 in CBPP. 
IL8 expression, while dramatically increased in both groups’ BAL samples, was 
greater in nonsurvivors.  This was reversed in biopsy and cytology samples, but only on 
Day 1.  The situation in BAL samples would appear to have a rational explanation in that 
the increased recruitment of neutrophils to the lung would result in oxidative damage 
that could negatively impact survival.  The IL8 expression in biopsy samples, however, 
would argue against such a hypothesis since the animals with greater expression 
survived.  The true situation may be a matter of both degree and time; bronchial biopsy 
samples exhibited both a lower total fold change and a shorter period of highly increased 
expression than did BAL.  Infected animals could potentially have a better chance of 
resolving less severe oxidative damage of short duration than profound oxidative 
damage lasting more than a week. 
Such comparisons as are presented here are unlikely to be useful in 
prognosticating survival of individual cattle, since standard response to a CBPP outbreak 
in most countries is immediate slaughter of any affected animals. Additionally, true 
recovery from CBPP cannot be inferred since even the survivor group still had lesions at 
necropsy.  However, this data may provide some indication of potential mediators of 
virulence, which in turn could provide clues toward intervention or vaccine development 
as well as disease pathogenesis.  Any conclusions drawn from this comparison must 
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keep in mind that the sample size in this study was very small and verification with 
larger groups of animals will be necessary to validate this data. 
In summary, specific host genes were identified that could provide insight into 
the mechanisms of differential strain virulence in MmmSC through understanding their 
effects on the host animal.  Additionally, comparison of gene expression between 
survivors and nonsurvivors of a highly pathogenic strain of MmmSC may also identify 
pathways involved in disease pathogenesis.   
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CHAPTER V 
 
CONCLUSIONS 
 
 Mycoplasma mycoides mycoides small colony is the causative agent of 
Contagious Bovine Pleuropneumonia, a devastating cause of cattle pneumonia affecting 
large parts of Africa, Asia and the Middle East.  MmmSC is one of a cluster of closely-
related mycoides organisms that are impossible to differentiate serologically.  MmmSC 
is the only bacterial pathogen on the OIE list A, and is of interest in the United States 
because of its potential for deliberate introduction as an agroterrorism agent.  The 
objective of this study was to establish a model of bovine infection with three strains of 
MmmSC not previously investigated, and to determine the bovine host response to 
infection with MmmSC through characterization of the transcriptome throughout 
infection.  The hypothesis was that MmmSC infection causes alterations in the host 
transcriptome that may provide insight into how the mycoplasma establishes and 
maintains infection through interaction with the host. 
 In order to test our hypothesis, we developed models of infection using 
endobronchial inoculation of one of three African/Australian MmmSC strains of varying 
pathogenicity.  Equal bacterial numbers of each strain were used.  Animals were 
followed through infection, recovery, euthanasia and necropsy, and a timeline of clinical 
disease expression was described for each MmmSC strain.  Gross and histologic 
evaluation of selected tissues completed the model.   
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 The next goal was to characterize the temporal transcriptional profile of the 
bovine host during infection with the virulent MmmSC strain Gladysdale.  Very little 
has been investigated with regard to the interaction of MmmSC with the host animal, 
and no gene expression studies have previously been conducted with this organism or its 
host.  Toward this end, weekly samples were obtained of bronchoalveolar lavage fluid, 
bronchial epithelium, nasal epithelium and blood from infected cattle.  Microarray 
analysis of RNA revealed a greatly upregulated transcriptional profile shortly after 
infection, with a gradual return of expression toward baseline levels over time.  Cellular 
pathways intimately involved with establishment and maintenance of disease were 
identified using in silico analysis, and numerous mechanistic genes were identified in 
each tissue type analyzed.  Many of the genes identified have not previously been 
associated with disease pathogenesis and further experimentation is required to elucidate 
their role in infection.   
 The next goal of this project was to directly compare gene expression of selected 
host genes between animals infected with each of the three MmmSC strains.  The host 
response to infection can itself cause a portion of the pathology of the disease, as many 
components of the immune system are potent inflammatory mediators.  Several genes, 
particularly cytokines and transcription factors, were found to be differentially expressed 
between the strains, indicating that they may play a role in disease pathogenesis.  Genes 
that appeared to influence disease severity included IL6, IL8, IL1B, IL18 and NFKBIA.  
Not all genes investigated proved to have differential expression between the strains; 
genes that did not demonstrate a link with differential disease severity were CALM2, 
  
155 
FTH1, MAPK1 and STAT3.  This does not eliminate these genes from a role in disease 
pathogenesis; they may be vitally important in the response to infection despite not being 
determinants of strain virulence.  Additional investigation, such as that using RNA 
interference, is needed to more definitively identify the precise role of each of the 
potentially outcome-influencing genes. 
 The final goal of this project was to investigate gene expression between 
survivors and nonsurvivors of infection with strain Gladysdale.  Differences in host gene 
expression between animals recovering from infection and those succumbing to 
infection with the same strain may highlight host genes important in the response to 
infection.  For example, a gene that is differentially expressed between survivors and 
nonsurvivors may represent a gene whose product is vital in resolving infection.  
Alternatively, it may represent a gene whose product, when overexpressed, is involved 
in self-damage and worsening of disease.  All genes evaluated demonstrated differential 
expression between survivors and nonsurvivors in at least one sample type; the nature of 
each gene’s influence on survival remains to be determined. 
 These discoveries may be extended through the use of additional techniques 
including RNA interference, laser capture microdissection, targeted lymphatic tissue 
sampling or lymphatic cannulation to further define pathways and genes expressed by 
the bovine host.  In addition, investigation of the very early host response (prior to 24 
hours) may yield insight into the mechanisms of establishment of infection.  Study of the 
causative organism will also provide valuable data.  Although mycoplasmas are highly 
resistant to genetic manipulation, their small genome would allow use of array-based 
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analysis techniques with relative ease.  Simultaneous exploration of host and bacterial 
gene expression in vivo would be particularly valuable, as identification of bacterial 
virulence factors in mycoplasmas has been elusive.   Synthesis of this information will 
improve understanding of the bovine:MmmSC interaction, potentially allowing the 
development of sensitive and specific cow-side diagnostics and effective, safe vaccines 
toward an ultimate goal of control or even eradication of this pathogen. 
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